{
  "civic.tid:15": {
    "id": "civic.tid:15",
    "label": "Erlotinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:337525",
          "label": "erlotinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:648",
              "type": "Disease",
              "label": "Pancreatic cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C43298"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C65530"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:4": {
    "id": "civic.tid:4",
    "label": "Vemurafenib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1147220",
          "label": "vemurafenib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:629",
              "type": "Disease",
              "label": "Melanoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3224"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:594",
              "type": "Disease",
              "label": "Erdheim-Chester disease",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C53972"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C64768"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
      "BRAF (V600E) Kinase Inhibitor RO5185426",
      "BRAF(V600E) Kinase Inhibitor RO5185426",
      "PLX-4032",
      "PLX4032",
      "RG 7204",
      "RG7204",
      "RO 5185426",
      "Zelboraf"
    ]
  },
  "civic.tid:187": {
    "id": "civic.tid:187",
    "label": "Osimertinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1721560",
          "label": "osimertinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C116377"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-",
      "AZD-9291",
      "AZD9291",
      "Mereletinib",
      "Tagrisso"
    ]
  },
  "civic.tid:146": {
    "id": "civic.tid:146",
    "label": "Afatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1430438",
          "label": "afatinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:25316",
              "type": "Disease",
              "label": "Non-small cell lung cancer squamous"
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C66940"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(2e)-N-(4-(3-Chloro-4-Fluoroanilino)-7-(((3s)-Oxolan-3-yl)Oxy)Quinoxazolin-6-yl)-4-(Dimethylamino)But-2-Enamide",
      "BIBW 2992",
      "BIBW2992"
    ]
  },
  "civic.ctid:QoPu2SO9N_zsHY4X6TMs5q3CLWJMHAQa": {
    "id": "civic.ctid:QoPu2SO9N_zsHY4X6TMs5q3CLWJMHAQa",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:570",
        "label": "Alpelisib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2169285",
              "label": "alpelisib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C94214"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BYL719",
          "Phosphoinositide 3-kinase Inhibitor BYL719",
          "Piqray"
        ]
      },
      {
        "id": "civic.tid:54",
        "label": "Fulvestrant",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282357",
              "label": "fulvestrant"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1379"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "7a-[9-[(4,4,5,5,5,-Pentafluoropentyl)sulphinyl]nonyl]-estra-1,3,5(10)-triene-3,17b-diol",
          "Faslodex",
          "Faslodex(ICI 182,780)",
          "ICI 182,780",
          "ICI 182780",
          "ZD9238"
        ]
      }
    ]
  },
  "civic.tid:654": {
    "id": "civic.tid:654",
    "label": "Sotorasib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2550714",
          "label": "sotorasib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C154287"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AMG 510",
      "AMG-510",
      "AMG510",
      "Lumakras"
    ]
  },
  "civic.ctid:P1PY89shAjemg7jquQ0V9pg1VnYnkPeK": {
    "id": "civic.ctid:P1PY89shAjemg7jquQ0V9pg1VnYnkPeK",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:483",
        "label": "Encorafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2049106",
              "label": "encorafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D008545",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C98283"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Braftovi",
          "LGX 818",
          "LGX-818",
          "LGX818"
        ]
      },
      {
        "id": "civic.tid:16",
        "label": "Cetuximab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:318341",
              "label": "cetuximab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D006258",
                  "type": "Disease",
                  "label": "Head and Neck Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4013"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002294",
                  "type": "Disease",
                  "label": "Carcinoma, Squamous Cell",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2929"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1723"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Cetuximab Biosimilar CDP-1",
          "Cetuximab Biosimilar CMAB009",
          "Cetuximab Biosimilar KL 140",
          "Chimeric Anti-EGFR Monoclonal Antibody",
          "Chimeric MoAb C225",
          "Chimeric Monoclonal Antibody C225",
          "Erbitux",
          "IMC-C225"
        ]
      }
    ]
  },
  "civic.ctid:oBrlcO23adoVXv51xh-5Wigy0QyDWtfr": {
    "id": "civic.ctid:oBrlcO23adoVXv51xh-5Wigy0QyDWtfr",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:22",
        "label": "Dabrafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1424911",
              "label": "dabrafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:675",
                  "type": "Disease",
                  "label": "Thyroid cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7510"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C82386"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BRAF Inhibitor GSK2118436",
          "Benzenesulfonamide, N-(3-(5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl)-2-fluorophenyl)-2,6-difluoro-",
          "GSK-2118436",
          "GSK-2118436A",
          "GSK2118436"
        ]
      },
      {
        "id": "civic.tid:19",
        "label": "Trametinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1425098",
              "label": "trametinib dimethyl sulfoxide"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C77908"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "GSK1120212",
          "JTP-74057",
          "MEK Inhibitor GSK1120212",
          "Mekinist",
          "N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide"
        ]
      }
    ]
  },
  "civic.tid:22": {
    "id": "civic.tid:22",
    "label": "Dabrafenib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1424911",
          "label": "dabrafenib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:629",
              "type": "Disease",
              "label": "Melanoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3224"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:675",
              "type": "Disease",
              "label": "Thyroid cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7510"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C82386"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "BRAF Inhibitor GSK2118436",
      "Benzenesulfonamide, N-(3-(5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl)-2-fluorophenyl)-2,6-difluoro-",
      "GSK-2118436",
      "GSK-2118436A",
      "GSK2118436"
    ]
  },
  "civic.tid:16": {
    "id": "civic.tid:16",
    "label": "Cetuximab",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:318341",
          "label": "cetuximab"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D015179",
              "type": "Disease",
              "label": "Colorectal Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2956"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D006258",
              "type": "Disease",
              "label": "Head and Neck Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4013"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D002294",
              "type": "Disease",
              "label": "Carcinoma, Squamous Cell",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2929"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C1723"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Cetuximab Biosimilar CDP-1",
      "Cetuximab Biosimilar CMAB009",
      "Cetuximab Biosimilar KL 140",
      "Chimeric Anti-EGFR Monoclonal Antibody",
      "Chimeric MoAb C225",
      "Chimeric Monoclonal Antibody C225",
      "Erbitux",
      "IMC-C225"
    ]
  },
  "civic.tid:44": {
    "id": "civic.tid:44",
    "label": "Dacomitinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2058848",
          "label": "dacomitinib anhydrous"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C53398"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(2E)-N-(4-((3-Chloro-4-Fluorophenyl)Amino)-7-Methoxyquinazolin-6-yl)-4-Piperidin-1-ylbut-2-Enamide",
      "EGFR Inhibitor PF-00299804",
      "PF-00299804",
      "PF-00299804-03",
      "PF-299804",
      "Vizimpro"
    ]
  },
  "civic.ctid:7g5X81wE2go4GE_fB45SjFamVMgpnwsA": {
    "id": "civic.ctid:7g5X81wE2go4GE_fB45SjFamVMgpnwsA",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:483",
        "label": "Encorafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2049106",
              "label": "encorafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D008545",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C98283"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Braftovi",
          "LGX 818",
          "LGX-818",
          "LGX818"
        ]
      },
      {
        "id": "civic.tid:485",
        "label": "Binimetinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2049122",
              "label": "binimetinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C84865"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ARRY-162",
          "ARRY-438162",
          "MEK162",
          "Mektovi"
        ]
      },
      {
        "id": "civic.tid:16",
        "label": "Cetuximab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:318341",
              "label": "cetuximab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D006258",
                  "type": "Disease",
                  "label": "Head and Neck Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4013"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002294",
                  "type": "Disease",
                  "label": "Carcinoma, Squamous Cell",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2929"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1723"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Cetuximab Biosimilar CDP-1",
          "Cetuximab Biosimilar CMAB009",
          "Cetuximab Biosimilar KL 140",
          "Chimeric Anti-EGFR Monoclonal Antibody",
          "Chimeric MoAb C225",
          "Chimeric Monoclonal Antibody C225",
          "Erbitux",
          "IMC-C225"
        ]
      }
    ]
  },
  "civic.tid:5": {
    "id": "civic.tid:5",
    "label": "Imatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:282388",
          "label": "imatinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:669",
              "type": "Disease",
              "label": "Systemic mastocytosis",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9235"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:582",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3174"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:24309",
              "type": "Disease",
              "label": "Acute lymphoblastic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3167"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:634",
              "type": "Disease",
              "label": "Myelodysplastic syndrome",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3247"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:602",
              "type": "Disease",
              "label": "Gastrointestinal stromal tumor",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3868"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:33893",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia pediatric"
            },
            {
              "id": "hemonc:667",
              "type": "Disease",
              "label": "Soft tissue sarcoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9306"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:616",
              "type": "Disease",
              "label": "Hypereosinophilic syndrome",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C27038"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C62035"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide"
    ]
  },
  "civic.tid:24385": {
    "id": "civic.tid:24385",
    "label": "Peginterferon Alfa-2b",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:253453",
          "label": "peginterferon alfa-2b"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D008545",
              "type": "Disease",
              "label": "Melanoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3224"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D019698",
              "type": "Disease",
              "label": "Hepatitis C, Chronic",
              "mappings": [
                {
                  "coding": {
                    "system": "mondo",
                    "code": "0005354"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C1845"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "PEG Interferon Alpha-2b",
      "PEG Intron",
      "PEG-IFN Alfa-2b",
      "PEG-IFN-a 2b",
      "PEG-Interferon Alfa-2b",
      "PEG-Intron",
      "Pegylated Interferon Alpha-2b",
      "Polyethylene Glycol IFN-A2b",
      "Polyethylene Glycol Interferon Alfa-2b",
      "SCH 54031",
      "Sylatron"
    ]
  },
  "civic.tsgid:MHwrYYGaDMmdgFLNboI18QBl-zDj5Wso": {
    "id": "civic.tsgid:MHwrYYGaDMmdgFLNboI18QBl-zDj5Wso",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:14",
        "label": "Gefitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:328134",
              "label": "gefitinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1855"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline",
          "Iressa",
          "N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholin) Propoxy]-4-quinazolinamine",
          "ZD 1839",
          "ZD1839"
        ]
      },
      {
        "id": "civic.tid:15",
        "label": "Erlotinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:337525",
              "label": "erlotinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:648",
                  "type": "Disease",
                  "label": "Pancreatic cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C43298"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C65530"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent"
      }
    ]
  },
  "civic.tid:227": {
    "id": "civic.tid:227",
    "label": "Ibrutinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1442981",
          "label": "ibrutinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:682",
              "type": "Disease",
              "label": "Waldenstroem macroglobulinemia"
            },
            {
              "id": "hemonc:605",
              "type": "Disease",
              "label": "Graft versus host disease",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3063"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:581",
              "type": "Disease",
              "label": "Chronic lymphocytic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3163"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:625",
              "type": "Disease",
              "label": "Mantle cell lymphoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4337"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:626",
              "type": "Disease",
              "label": "Marginal zone lymphoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4341"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C81934"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-Propen-1-one, 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-",
      "BTK Inhibitor PCI-32765",
      "CRA-032765",
      "Imbruvica",
      "PCI-32765"
    ]
  },
  "civic.tid:91": {
    "id": "civic.tid:91",
    "label": "Rociletinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C99905",
          "label": "Rociletinib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C99905"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "CO-1686",
      "N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)prop-2-enamide"
    ]
  },
  "civic.tsgid:TgPtIuv9V-lbf4OQZ9w7ag3sI2QRhkFz": {
    "id": "civic.tsgid:TgPtIuv9V-lbf4OQZ9w7ag3sI2QRhkFz",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:85",
        "label": "Gemcitabine",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:12574",
              "label": "gemcitabine"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:645",
                  "type": "Disease",
                  "label": "Ovarian cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7431"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:648",
                  "type": "Disease",
                  "label": "Pancreatic cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C43298"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C66876"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-(2-Oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose",
          "2'Deoxy-2',2'-Difluorocytidine",
          "DFdC",
          "DFdCyd",
          "Difluorodeoxycytidine"
        ]
      },
      {
        "id": "civic.tid:96",
        "label": "Vinorelbine",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:39541",
              "label": "vinorelbine"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1275"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "3',4'-Didehydro-4'-deoxy-C'-norvincaleukoblastine",
          "5'-Nor-Anhydrovinblastine",
          "Dihydroxydeoxynorvinkaleukoblastine",
          "Nor-5'-Anhydrovinblastine"
        ]
      },
      {
        "id": "civic.tid:73",
        "label": "Docetaxel",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1299922",
              "label": "docetaxel anhydrous"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:658",
                  "type": "Disease",
                  "label": "Prostate cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7378"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:608",
                  "type": "Disease",
                  "label": "Head and neck cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4013"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:601",
                  "type": "Disease",
                  "label": "Gastric cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9331"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1526"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Docecad",
          "N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol",
          "RP56976",
          "Taxotere",
          "Taxotere Injection Concentrate",
          "[2aR-[2a Alphaa,4beta,4a Beta,6beta,9alpha,(alphaR*,betaS*),-11alpha,12alpha,12a Alpha,12b Alpha]]-beta-[[(1,1-dimethylethoxy)carbonyl]-amino]-alpha-hydroxybenzemepropanoic Acid 12b-(Acetyloxy)-12(benzyloxy)-2a,3,4,4a,5,6,8,10,11,12,12a,12b-dodecahydeo-4,-6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester"
        ]
      }
    ]
  },
  "civic.tsgid:xFFut3eEUjgeT2G4uNtiphTfxMQw9B4X": {
    "id": "civic.tsgid:xFFut3eEUjgeT2G4uNtiphTfxMQw9B4X",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:93",
        "label": "Carboplatin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:40048",
              "label": "carboplatin"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:645",
                  "type": "Disease",
                  "label": "Ovarian cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7431"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1282"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(SP-4-2)-diammine[1,1-cyclobutanedicarboxylato(2--)-O,O']platinum",
          "1,1-cyclobutanedicarboxylic Acid Platinum Complex",
          "Blastocarb",
          "CBDCA",
          "Carboplat",
          "Carboplatin Hexal",
          "Carboplatino",
          "Carboplatinum",
          "Carbosin",
          "Carbosol",
          "Carbotec",
          "Cis-Diammine(cyclobutane-1,1-dicarboxylato)platinum",
          "Cis-diammine(1,1-cyclobutanedicarboxylato) Platinum(II)",
          "Cis-diammine(cyclobutanedicarboxylato)platinum II",
          "Displata",
          "Ercar",
          "JM-8",
          "Nealorin",
          "Novoplatinum",
          "Paraplat",
          "Paraplatin",
          "Paraplatin AQ",
          "Paraplatine",
          "Platinum, Diammine(1,1-cyclobutanedicarboxylato(2-))-, (SP-4-2)",
          "Platinwas",
          "Ribocarbo"
        ]
      },
      {
        "id": "civic.tid:326",
        "label": "Cisplatin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2555",
              "label": "cisplatin"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:671",
                  "type": "Disease",
                  "label": "Testicular cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C5053"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:645",
                  "type": "Disease",
                  "label": "Ovarian cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7431"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:569",
                  "type": "Disease",
                  "label": "Bladder cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9334"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C376"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(SP-4-2)-Diamminedichloroplatinum",
          "Abiplatin",
          "Blastolem",
          "Briplatin",
          "CDDP",
          "Cis-diammine-dichloroplatinum",
          "Cis-diamminedichloridoplatinum",
          "Cis-diamminedichloro Platinum (II)",
          "Cis-diamminedichloroplatinum",
          "Cis-dichloroammine Platinum (II)",
          "Cis-platinous Diamine Dichloride",
          "Cis-platinum",
          "Cis-platinum II",
          "Cis-platinum II Diamine Dichloride",
          "Cismaplat",
          "Cisplatina",
          "Cisplatinum",
          "Cisplatyl",
          "Citoplatino",
          "Citosin",
          "Cysplatyna",
          "DDP",
          "Lederplatin",
          "Metaplatin",
          "Neoplatin",
          "Peyrone's Chloride",
          "Peyrone's Salt",
          "Placis",
          "Plastistil",
          "Platamine",
          "Platiblastin",
          "Platiblastin-S",
          "Platinex",
          "Platinol",
          "Platinol- AQ",
          "Platinol-AQ",
          "Platinol-AQ VHA Plus",
          "Platinoxan",
          "Platinum",
          "Platinum Diamminodichloride",
          "Platinum, Diaminedichloro-, Cis- (8CI)",
          "Platiran",
          "Platistin",
          "Platosin"
        ]
      }
    ]
  },
  "civic.tid:326": {
    "id": "civic.tid:326",
    "label": "Cisplatin",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2555",
          "label": "cisplatin"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:671",
              "type": "Disease",
              "label": "Testicular cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C5053"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:645",
              "type": "Disease",
              "label": "Ovarian cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7431"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:569",
              "type": "Disease",
              "label": "Bladder cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9334"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C376"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(SP-4-2)-Diamminedichloroplatinum",
      "Abiplatin",
      "Blastolem",
      "Briplatin",
      "CDDP",
      "Cis-diammine-dichloroplatinum",
      "Cis-diamminedichloridoplatinum",
      "Cis-diamminedichloro Platinum (II)",
      "Cis-diamminedichloroplatinum",
      "Cis-dichloroammine Platinum (II)",
      "Cis-platinous Diamine Dichloride",
      "Cis-platinum",
      "Cis-platinum II",
      "Cis-platinum II Diamine Dichloride",
      "Cismaplat",
      "Cisplatina",
      "Cisplatinum",
      "Cisplatyl",
      "Citoplatino",
      "Citosin",
      "Cysplatyna",
      "DDP",
      "Lederplatin",
      "Metaplatin",
      "Neoplatin",
      "Peyrone's Chloride",
      "Peyrone's Salt",
      "Placis",
      "Plastistil",
      "Platamine",
      "Platiblastin",
      "Platiblastin-S",
      "Platinex",
      "Platinol",
      "Platinol- AQ",
      "Platinol-AQ",
      "Platinol-AQ VHA Plus",
      "Platinoxan",
      "Platinum",
      "Platinum Diamminodichloride",
      "Platinum, Diaminedichloro-, Cis- (8CI)",
      "Platiran",
      "Platistin",
      "Platosin"
    ]
  },
  "civic.tsgid:7IxyhCwID0QYyVCP2xuIyYvwwu-S_HrZ": {
    "id": "civic.tsgid:7IxyhCwID0QYyVCP2xuIyYvwwu-S_HrZ",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:16",
        "label": "Cetuximab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:318341",
              "label": "cetuximab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D006258",
                  "type": "Disease",
                  "label": "Head and Neck Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4013"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002294",
                  "type": "Disease",
                  "label": "Carcinoma, Squamous Cell",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2929"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1723"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Cetuximab Biosimilar CDP-1",
          "Cetuximab Biosimilar CMAB009",
          "Cetuximab Biosimilar KL 140",
          "Chimeric Anti-EGFR Monoclonal Antibody",
          "Chimeric MoAb C225",
          "Chimeric Monoclonal Antibody C225",
          "Erbitux",
          "IMC-C225"
        ]
      },
      {
        "id": "civic.tid:28",
        "label": "Panitumumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:263034",
              "label": "panitumumab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1857"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABX-EGF",
          "ABX-EGF Monoclonal Antibody",
          "ABX-EGF, Clone E7.6.3",
          "E7.6.3",
          "Human IgG2K Monoclonal Antibody",
          "MoAb ABX-EGF",
          "MoAb E7.6.3",
          "Monoclonal Antibody ABX-EGF",
          "Monoclonal Antibody E7.6.3",
          "Vectibix"
        ]
      }
    ]
  },
  "civic.tid:84": {
    "id": "civic.tid:84",
    "label": "Trastuzumab",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2103478",
          "label": "trastuzumab-dkst"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D001943",
              "type": "Disease",
              "label": "Breast Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2910"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C1647"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "ABP 980",
      "ALT02",
      "Anti-ERB-2",
      "Anti-HER2/c-erbB2 Monoclonal Antibody",
      "Anti-c-ERB-2",
      "Anti-c-erbB2 Monoclonal Antibody",
      "Anti-erbB-2",
      "Anti-erbB2 Monoclonal Antibody",
      "Anti-p185-HER2",
      "C-erb-2 Monoclonal Antibody",
      "HER2 Monoclonal Antibody",
      "Herceptin",
      "Herceptin Biosimilar PF-05280014",
      "Herceptin Trastuzumab Biosimilar PF-05280014",
      "Herzuma",
      "Immunoglobulin G 1 (Human-Mouse Monoclonal RhuMab HER2gamma1-Chain Antihuman P185(Sup C-erbB2) Receptor), Disulfide With Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer",
      "Kanjinti",
      "MoAb HER2",
      "Monoclonal Antibody C-erb-2",
      "Monoclonal Antibody HER2",
      "Ogivri",
      "Ontruzant",
      "PF-05280014",
      "RO0452317",
      "RhuMAb HER2",
      "SB3",
      "Trastuzumab Biosimilar ABP 980",
      "Trastuzumab Biosimilar ALT02",
      "Trastuzumab Biosimilar EG12014",
      "Trastuzumab Biosimilar HLX02",
      "Trastuzumab Biosimilar PF-05280014",
      "Trastuzumab Biosimilar SB3",
      "Trastuzumab Biosimilar SIBP-01",
      "Trastuzumab-anns",
      "Trastuzumab-dkst",
      "Trastuzumab-dttb",
      "Trastuzumab-pkrb",
      "Trastuzumab-qyyp",
      "Trazimera"
    ]
  },
  "civic.ctid:sUZF6fX-tmv7MQt76twjivm3eJ5Znrzm": {
    "id": "civic.ctid:sUZF6fX-tmv7MQt76twjivm3eJ5Znrzm",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:4",
        "label": "Vemurafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1147220",
              "label": "vemurafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:594",
                  "type": "Disease",
                  "label": "Erdheim-Chester disease",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C53972"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C64768"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
          "BRAF (V600E) Kinase Inhibitor RO5185426",
          "BRAF(V600E) Kinase Inhibitor RO5185426",
          "PLX-4032",
          "PLX4032",
          "RG 7204",
          "RG7204",
          "RO 5185426",
          "Zelboraf"
        ]
      },
      {
        "id": "civic.tid:342",
        "label": "Cobimetinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1722365",
              "label": "cobimetinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C68923"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Cotellic",
          "GDC-0973",
          "MEK Inhibitor GDC-0973",
          "XL518"
        ]
      }
    ]
  },
  "civic.tid:323": {
    "id": "civic.tid:323",
    "label": "Midostaurin",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1919083",
          "label": "midostaurin"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:669",
              "type": "Disease",
              "label": "Systemic mastocytosis",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9235"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:552",
              "type": "Disease",
              "label": "Acute myeloid leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3171"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C1872"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "CGP 41251",
      "CGP41251",
      "N-Benzoyl-Staurosporine",
      "N-Benzoylstaurosporine",
      "PKC-412",
      "PKC412",
      "Rydapt"
    ]
  },
  "civic.tid:420": {
    "id": "civic.tid:420",
    "label": "Fluorouracil",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:4492",
          "label": "fluorouracil"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": []
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C505"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2,4-Dioxo-5-fluoropyrimidine",
      "5 FU",
      "5 Fluorouracil",
      "5 Fluorouracilum",
      "5-FU",
      "5-Fluoro-2,4(1H, 3H)-pyrimidinedione",
      "5-Fluoro-2,4(1H,3H)-pyrimidinedione",
      "5-Fluorouracil",
      "5-Fluracil",
      "5FU",
      "AccuSite",
      "Adrucil",
      "Carac",
      "Fluoro Uracil",
      "Fluouracil",
      "Flurablastin",
      "Fluracedyl",
      "Fluracil",
      "Fluril",
      "Fluroblastin",
      "Ribofluor",
      "Ro 2-9757",
      "Ro-2-9757"
    ]
  },
  "civic.ctid:rF1JcnGq_-VTc0yiCsNIORfNqXQCC3yM": {
    "id": "civic.ctid:rF1JcnGq_-VTc0yiCsNIORfNqXQCC3yM",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:4",
        "label": "Vemurafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1147220",
              "label": "vemurafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:594",
                  "type": "Disease",
                  "label": "Erdheim-Chester disease",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C53972"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C64768"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
          "BRAF (V600E) Kinase Inhibitor RO5185426",
          "BRAF(V600E) Kinase Inhibitor RO5185426",
          "PLX-4032",
          "PLX4032",
          "RG 7204",
          "RG7204",
          "RO 5185426",
          "Zelboraf"
        ]
      },
      {
        "id": "civic.tid:16",
        "label": "Cetuximab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:318341",
              "label": "cetuximab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D006258",
                  "type": "Disease",
                  "label": "Head and Neck Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4013"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002294",
                  "type": "Disease",
                  "label": "Carcinoma, Squamous Cell",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2929"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1723"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Cetuximab Biosimilar CDP-1",
          "Cetuximab Biosimilar CMAB009",
          "Cetuximab Biosimilar KL 140",
          "Chimeric Anti-EGFR Monoclonal Antibody",
          "Chimeric MoAb C225",
          "Chimeric Monoclonal Antibody C225",
          "Erbitux",
          "IMC-C225"
        ]
      },
      {
        "id": "civic.tid:101",
        "label": "Irinotecan",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:153329",
              "label": "irinotecan hydrochloride"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:46096",
                  "type": "Disease",
                  "label": "Colorectal cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4978"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62040"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(+)-(4S)-4,11-diethyl-4-hydroxy-9-[(4-piperidino-piperidino)carbonyloxy]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinol-3,14,(4H,12H)-dione",
          "(+)-7-ethyl-10-hydroxycamptothecine 10-[1,4'-bipiperidine]-1'-carboxylate",
          "7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin",
          "[1,4'-bipiperidine]-1'-carboxylic Acid (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl Ester"
        ]
      }
    ]
  },
  "civic.tid:19": {
    "id": "civic.tid:19",
    "label": "Trametinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1425098",
          "label": "trametinib dimethyl sulfoxide"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C77908"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "GSK1120212",
      "JTP-74057",
      "MEK Inhibitor GSK1120212",
      "Mekinist",
      "N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide"
    ]
  },
  "civic.tid:14": {
    "id": "civic.tid:14",
    "label": "Gefitinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:328134",
          "label": "gefitinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C1855"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline",
      "Iressa",
      "N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholin) Propoxy]-4-quinazolinamine",
      "ZD 1839",
      "ZD1839"
    ]
  },
  "civic.ctid:B-IrkOe3eeSyqxT7T9-Dll8eWlNYv5mm": {
    "id": "civic.ctid:B-IrkOe3eeSyqxT7T9-Dll8eWlNYv5mm",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:326",
        "label": "Cisplatin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2555",
              "label": "cisplatin"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:671",
                  "type": "Disease",
                  "label": "Testicular cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C5053"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:645",
                  "type": "Disease",
                  "label": "Ovarian cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7431"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:569",
                  "type": "Disease",
                  "label": "Bladder cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9334"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C376"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(SP-4-2)-Diamminedichloroplatinum",
          "Abiplatin",
          "Blastolem",
          "Briplatin",
          "CDDP",
          "Cis-diammine-dichloroplatinum",
          "Cis-diamminedichloridoplatinum",
          "Cis-diamminedichloro Platinum (II)",
          "Cis-diamminedichloroplatinum",
          "Cis-dichloroammine Platinum (II)",
          "Cis-platinous Diamine Dichloride",
          "Cis-platinum",
          "Cis-platinum II",
          "Cis-platinum II Diamine Dichloride",
          "Cismaplat",
          "Cisplatina",
          "Cisplatinum",
          "Cisplatyl",
          "Citoplatino",
          "Citosin",
          "Cysplatyna",
          "DDP",
          "Lederplatin",
          "Metaplatin",
          "Neoplatin",
          "Peyrone's Chloride",
          "Peyrone's Salt",
          "Placis",
          "Plastistil",
          "Platamine",
          "Platiblastin",
          "Platiblastin-S",
          "Platinex",
          "Platinol",
          "Platinol- AQ",
          "Platinol-AQ",
          "Platinol-AQ VHA Plus",
          "Platinoxan",
          "Platinum",
          "Platinum Diamminodichloride",
          "Platinum, Diaminedichloro-, Cis- (8CI)",
          "Platiran",
          "Platistin",
          "Platosin"
        ]
      },
      {
        "id": "civic.tid:420",
        "label": "Fluorouracil",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:4492",
              "label": "fluorouracil"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": []
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C505"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "2,4-Dioxo-5-fluoropyrimidine",
          "5 FU",
          "5 Fluorouracil",
          "5 Fluorouracilum",
          "5-FU",
          "5-Fluoro-2,4(1H, 3H)-pyrimidinedione",
          "5-Fluoro-2,4(1H,3H)-pyrimidinedione",
          "5-Fluorouracil",
          "5-Fluracil",
          "5FU",
          "AccuSite",
          "Adrucil",
          "Carac",
          "Fluoro Uracil",
          "Fluouracil",
          "Flurablastin",
          "Fluracedyl",
          "Fluracil",
          "Fluril",
          "Fluroblastin",
          "Ribofluor",
          "Ro 2-9757",
          "Ro-2-9757"
        ]
      }
    ]
  },
  "civic.tid:112": {
    "id": "civic.tid:112",
    "label": "Capivasertib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C102564",
          "label": "Capivasertib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C102564"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AZD5363"
    ]
  },
  "civic.ctid:TC0qf-K34RiO4MPOvi-7wmgAjjt7va7T": {
    "id": "civic.ctid:TC0qf-K34RiO4MPOvi-7wmgAjjt7va7T",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:22",
        "label": "Dabrafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1424911",
              "label": "dabrafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:675",
                  "type": "Disease",
                  "label": "Thyroid cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7510"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C82386"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BRAF Inhibitor GSK2118436",
          "Benzenesulfonamide, N-(3-(5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl)-2-fluorophenyl)-2,6-difluoro-",
          "GSK-2118436",
          "GSK-2118436A",
          "GSK2118436"
        ]
      },
      {
        "id": "civic.tid:28",
        "label": "Panitumumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:263034",
              "label": "panitumumab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1857"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABX-EGF",
          "ABX-EGF Monoclonal Antibody",
          "ABX-EGF, Clone E7.6.3",
          "E7.6.3",
          "Human IgG2K Monoclonal Antibody",
          "MoAb ABX-EGF",
          "MoAb E7.6.3",
          "Monoclonal Antibody ABX-EGF",
          "Monoclonal Antibody E7.6.3",
          "Vectibix"
        ]
      },
      {
        "id": "civic.tid:19",
        "label": "Trametinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1425098",
              "label": "trametinib dimethyl sulfoxide"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C77908"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "GSK1120212",
          "JTP-74057",
          "MEK Inhibitor GSK1120212",
          "Mekinist",
          "N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide"
        ]
      }
    ]
  },
  "civic.tid:696": {
    "id": "civic.tid:696",
    "label": "Akt/ERK Inhibitor ONC201",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C113792",
          "label": "Akt/ERK Inhibitor ONC201"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C113792"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "ONC-201",
      "ONC201",
      "TIC10"
    ]
  },
  "civic.tid:144": {
    "id": "civic.tid:144",
    "label": "Cabozantinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1363267",
          "label": "cabozantinib s-malate"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:65823",
              "type": "Disease",
              "label": "Thyroid cancer differentiated"
            },
            {
              "id": "hemonc:660",
              "type": "Disease",
              "label": "Renal cell carcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9385"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:612",
              "type": "Disease",
              "label": "Hepatocellular carcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3099"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:68942",
              "type": "Disease",
              "label": "Thyroid cancer medullary"
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C52200"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1,1-Cyclopropanedicarboxamide, N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- Fluorophenyl)-",
      "N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1- Dicarboxamide"
    ]
  },
  "civic.tid:20999": {
    "id": "civic.tid:20999",
    "label": "KRAS G12C Inhibitor GDC-6036",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C173995",
          "label": "Divarasib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C173995"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "GDC 6036",
      "GDC-6036",
      "GDC6036"
    ]
  },
  "civic.tid:27": {
    "id": "civic.tid:27",
    "label": "Regorafenib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1312397",
          "label": "regorafenib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D015179",
              "type": "Disease",
              "label": "Colorectal Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2956"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C78204"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide",
      "BAY 73-4506",
      "REGORAFENIB ANHYDROUS",
      "Stivarga"
    ]
  },
  "civic.tid:157": {
    "id": "civic.tid:157",
    "label": "Sunitinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:357977",
          "label": "sunitinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:647",
              "type": "Disease",
              "label": "Pancreatic NET",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C27720"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:602",
              "type": "Disease",
              "label": "Gastrointestinal stromal tumor",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3868"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:660",
              "type": "Disease",
              "label": "Renal cell carcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9385"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C71622"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-"
    ]
  },
  "civic.tid:81": {
    "id": "civic.tid:81",
    "label": "Paclitaxel",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:56946",
          "label": "paclitaxel"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:645",
              "type": "Disease",
              "label": "Ovarian cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7431"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:54036",
              "type": "Disease",
              "label": "Kaposi sarcoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9087"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C1411"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "5Beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one, 4,10-Diacetate 2-Benzoate 13-Ester With (2R,3S)-N-Benzoyl-3-phenylisoserine",
      "Anzatax",
      "Asotax",
      "Bristaxol",
      "Praxel",
      "Taxol",
      "Taxol Konzentrat",
      "[2aR-[2a Alpha,4beta,4a Beta,6beta,9alpha(alphaR*,betaS*),-11alpha,12alpha,12a Alpha,12b Alpha]]-beta-(benzoylamino)-alpha-hydroxybenzene-propanoic Acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-1a,33,4,-41,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-41,8,-12,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester"
    ]
  },
  "civic.ctid:AxHYAnCZAUw1ShJYYZKndWIE3M53hjHd": {
    "id": "civic.ctid:AxHYAnCZAUw1ShJYYZKndWIE3M53hjHd",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:81",
        "label": "Paclitaxel",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:56946",
              "label": "paclitaxel"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:645",
                  "type": "Disease",
                  "label": "Ovarian cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7431"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:54036",
                  "type": "Disease",
                  "label": "Kaposi sarcoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9087"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1411"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "5Beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one, 4,10-Diacetate 2-Benzoate 13-Ester With (2R,3S)-N-Benzoyl-3-phenylisoserine",
          "Anzatax",
          "Asotax",
          "Bristaxol",
          "Praxel",
          "Taxol",
          "Taxol Konzentrat",
          "[2aR-[2a Alpha,4beta,4a Beta,6beta,9alpha(alphaR*,betaS*),-11alpha,12alpha,12a Alpha,12b Alpha]]-beta-(benzoylamino)-alpha-hydroxybenzene-propanoic Acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-1a,33,4,-41,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-41,8,-12,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester"
        ]
      },
      {
        "id": "civic.tid:93",
        "label": "Carboplatin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:40048",
              "label": "carboplatin"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:645",
                  "type": "Disease",
                  "label": "Ovarian cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7431"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1282"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(SP-4-2)-diammine[1,1-cyclobutanedicarboxylato(2--)-O,O']platinum",
          "1,1-cyclobutanedicarboxylic Acid Platinum Complex",
          "Blastocarb",
          "CBDCA",
          "Carboplat",
          "Carboplatin Hexal",
          "Carboplatino",
          "Carboplatinum",
          "Carbosin",
          "Carbosol",
          "Carbotec",
          "Cis-Diammine(cyclobutane-1,1-dicarboxylato)platinum",
          "Cis-diammine(1,1-cyclobutanedicarboxylato) Platinum(II)",
          "Cis-diammine(cyclobutanedicarboxylato)platinum II",
          "Displata",
          "Ercar",
          "JM-8",
          "Nealorin",
          "Novoplatinum",
          "Paraplat",
          "Paraplatin",
          "Paraplatin AQ",
          "Paraplatine",
          "Platinum, Diammine(1,1-cyclobutanedicarboxylato(2-))-, (SP-4-2)",
          "Platinwas",
          "Ribocarbo"
        ]
      }
    ]
  },
  "civic.tid:6": {
    "id": "civic.tid:6",
    "label": "Sorafenib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:495881",
          "label": "sorafenib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:65823",
              "type": "Disease",
              "label": "Thyroid cancer differentiated"
            },
            {
              "id": "hemonc:612",
              "type": "Disease",
              "label": "Hepatocellular carcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3099"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:660",
              "type": "Disease",
              "label": "Renal cell carcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9385"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C61948"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "BA4 43 9006",
      "BAY 43-9006",
      "Bay-439006"
    ]
  },
  "civic.ctid:aqQX-Uu5M67jU4vqRwbOB7diuYQozPtZ": {
    "id": "civic.ctid:aqQX-Uu5M67jU4vqRwbOB7diuYQozPtZ",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:4",
        "label": "Vemurafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1147220",
              "label": "vemurafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:594",
                  "type": "Disease",
                  "label": "Erdheim-Chester disease",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C53972"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C64768"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
          "BRAF (V600E) Kinase Inhibitor RO5185426",
          "BRAF(V600E) Kinase Inhibitor RO5185426",
          "PLX-4032",
          "PLX4032",
          "RG 7204",
          "RG7204",
          "RO 5185426",
          "Zelboraf"
        ]
      },
      {
        "id": "civic.tid:28",
        "label": "Panitumumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:263034",
              "label": "panitumumab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1857"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABX-EGF",
          "ABX-EGF Monoclonal Antibody",
          "ABX-EGF, Clone E7.6.3",
          "E7.6.3",
          "Human IgG2K Monoclonal Antibody",
          "MoAb ABX-EGF",
          "MoAb E7.6.3",
          "Monoclonal Antibody ABX-EGF",
          "Monoclonal Antibody E7.6.3",
          "Vectibix"
        ]
      }
    ]
  },
  "civic.tid:237": {
    "id": "civic.tid:237",
    "label": "Oxaliplatin",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:32592",
          "label": "oxaliplatin"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:46096",
              "type": "Disease",
              "label": "Colorectal cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4978"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:585",
              "type": "Disease",
              "label": "Colon cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9242"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C1181"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1-OHP",
      "Ai Heng",
      "Aiheng",
      "DACPLAT",
      "Dacotin",
      "Diaminocyclohexane Oxalatoplatinum",
      "ELOXATIN",
      "Eloxatine",
      "JM-83",
      "Oxalato (1R,2R-cyclohexanediamine)platinum(II)",
      "Oxalato (trans-l-1,2-diaminocyclohexane)platinum(II)",
      "Oxalatoplatin",
      "Oxalatoplatinum",
      "RP 54780",
      "RP-54780",
      "SR-96669",
      "Trans-l DACH Oxalatoplatinum",
      "Trans-l Diaminocyclohexane Oxalatoplatinum",
      "[(1R,-2R)-1,2-cyclohexanediamine-N,N'][oxalato (2--)-O,O']platinum",
      "[SP-4-2-(1R-trans)]-(1,2,cyclohexanediamine-N,N')[ethanedioato(2--)-O,O']platinum"
    ]
  },
  "civic.tid:101": {
    "id": "civic.tid:101",
    "label": "Irinotecan",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:153329",
          "label": "irinotecan hydrochloride"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:46096",
              "type": "Disease",
              "label": "Colorectal cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4978"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C62040"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(+)-(4S)-4,11-diethyl-4-hydroxy-9-[(4-piperidino-piperidino)carbonyloxy]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinol-3,14,(4H,12H)-dione",
      "(+)-7-ethyl-10-hydroxycamptothecine 10-[1,4'-bipiperidine]-1'-carboxylate",
      "7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin",
      "[1,4'-bipiperidine]-1'-carboxylic Acid (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl Ester"
    ]
  },
  "civic.ctid:Ak6hp_rMbp-qqpqM6XULZHux5GbB8qFG": {
    "id": "civic.ctid:Ak6hp_rMbp-qqpqM6XULZHux5GbB8qFG",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:33",
        "label": "Bevacizumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2046138",
              "label": "bevacizumab-awwb"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002289",
                  "type": "Disease",
                  "label": "Carcinoma, Non-Small-Cell Lung",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D003110",
                  "type": "Disease",
                  "label": "Colonic Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2953"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002583",
                  "type": "Disease",
                  "label": "Uterine Cervical Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9311"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002292",
                  "type": "Disease",
                  "label": "Carcinoma, Renal Cell",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D005909",
                  "type": "Disease",
                  "label": "Glioblastoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3058"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C2039"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABP 215",
          "Anti-VEGF",
          "Anti-VEGF Humanized Monoclonal Antibody",
          "Anti-VEGF RhuMAb",
          "Avastin",
          "BP102",
          "BP102 Biosimilar",
          "Bevacizumab Awwb",
          "Bevacizumab Biosimilar ABP 215",
          "Bevacizumab Biosimilar BEVZ92",
          "Bevacizumab Biosimilar BI 695502",
          "Bevacizumab Biosimilar CBT 124",
          "Bevacizumab Biosimilar CT-P16",
          "Bevacizumab Biosimilar FKB238",
          "Bevacizumab Biosimilar GB-222",
          "Bevacizumab Biosimilar HD204",
          "Bevacizumab Biosimilar HLX04",
          "Bevacizumab Biosimilar IBI305",
          "Bevacizumab Biosimilar LY01008",
          "Bevacizumab Biosimilar MIL60",
          "Bevacizumab Biosimilar MYL-1402O",
          "Bevacizumab Biosimilar Mvasi",
          "Bevacizumab Biosimilar QL 1101",
          "Bevacizumab Biosimilar RPH-001",
          "Bevacizumab Biosimilar SCT501",
          "Bevacizumab Biosimilar Zirabev",
          "Bevacizumab-awwb",
          "Bevacizumab-bvzr",
          "HD204",
          "Immunoglobulin G1 (Human-Mouse Monoclonal RhuMab-VEGF Gamma-Chain Anti-Human Vascular Endothelial Growth Factor), Disulfide With Human-Mouse Monoclonal RhuMab-VEGF Light Chain, Dimer",
          "MYL-1402O",
          "Mvasi",
          "Recombinant Humanized Anti-VEGF Monoclonal Antibody",
          "RhuMab-VEGF",
          "SCT501",
          "Zirabev"
        ]
      },
      {
        "id": "civic.tid:32",
        "label": "Capecitabine",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:194000",
              "label": "capecitabine"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:46096",
                  "type": "Disease",
                  "label": "Colorectal cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4978"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:585",
                  "type": "Disease",
                  "label": "Colon cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9242"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1794"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine",
          "Ro 09-1978/000",
          "Xeloda"
        ]
      },
      {
        "id": "civic.tid:237",
        "label": "Oxaliplatin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:32592",
              "label": "oxaliplatin"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:46096",
                  "type": "Disease",
                  "label": "Colorectal cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4978"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:585",
                  "type": "Disease",
                  "label": "Colon cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9242"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1181"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-OHP",
          "Ai Heng",
          "Aiheng",
          "DACPLAT",
          "Dacotin",
          "Diaminocyclohexane Oxalatoplatinum",
          "ELOXATIN",
          "Eloxatine",
          "JM-83",
          "Oxalato (1R,2R-cyclohexanediamine)platinum(II)",
          "Oxalato (trans-l-1,2-diaminocyclohexane)platinum(II)",
          "Oxalatoplatin",
          "Oxalatoplatinum",
          "RP 54780",
          "RP-54780",
          "SR-96669",
          "Trans-l DACH Oxalatoplatinum",
          "Trans-l Diaminocyclohexane Oxalatoplatinum",
          "[(1R,-2R)-1,2-cyclohexanediamine-N,N'][oxalato (2--)-O,O']platinum",
          "[SP-4-2-(1R-trans)]-(1,2,cyclohexanediamine-N,N')[ethanedioato(2--)-O,O']platinum"
        ]
      }
    ]
  },
  "civic.ctid:TJUHf9p152aDhRuAJ6lB5jfabJYZcqE_": {
    "id": "civic.ctid:TJUHf9p152aDhRuAJ6lB5jfabJYZcqE_",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:19",
        "label": "Trametinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1425098",
              "label": "trametinib dimethyl sulfoxide"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C77908"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "GSK1120212",
          "JTP-74057",
          "MEK Inhibitor GSK1120212",
          "Mekinist",
          "N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide"
        ]
      },
      {
        "id": "civic.tid:28",
        "label": "Panitumumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:263034",
              "label": "panitumumab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1857"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABX-EGF",
          "ABX-EGF Monoclonal Antibody",
          "ABX-EGF, Clone E7.6.3",
          "E7.6.3",
          "Human IgG2K Monoclonal Antibody",
          "MoAb ABX-EGF",
          "MoAb E7.6.3",
          "Monoclonal Antibody ABX-EGF",
          "Monoclonal Antibody E7.6.3",
          "Vectibix"
        ]
      }
    ]
  },
  "civic.tid:243": {
    "id": "civic.tid:243",
    "label": "MEK Inhibitor RO4987655",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C82696",
          "label": "MEK Inhibitor RO4987655"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C82696"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "RO-4987655",
      "RO4987655"
    ]
  },
  "civic.ctid:XLPSZcKSHPHqVNFvaTkpEccouN1BleTZ": {
    "id": "civic.ctid:XLPSZcKSHPHqVNFvaTkpEccouN1BleTZ",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:73",
        "label": "Docetaxel",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1299922",
              "label": "docetaxel anhydrous"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:658",
                  "type": "Disease",
                  "label": "Prostate cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7378"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:608",
                  "type": "Disease",
                  "label": "Head and neck cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4013"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:601",
                  "type": "Disease",
                  "label": "Gastric cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9331"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1526"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Docecad",
          "N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol",
          "RP56976",
          "Taxotere",
          "Taxotere Injection Concentrate",
          "[2aR-[2a Alphaa,4beta,4a Beta,6beta,9alpha,(alphaR*,betaS*),-11alpha,12alpha,12a Alpha,12b Alpha]]-beta-[[(1,1-dimethylethoxy)carbonyl]-amino]-alpha-hydroxybenzemepropanoic Acid 12b-(Acetyloxy)-12(benzyloxy)-2a,3,4,4a,5,6,8,10,11,12,12a,12b-dodecahydeo-4,-6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester"
        ]
      },
      {
        "id": "civic.tid:63",
        "label": "Selumetinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2289380",
              "label": "selumetinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": []
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C66939"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ARRY-142886",
          "AZD6244",
          "MEK Inhibitor AZD6244"
        ]
      }
    ]
  },
  "civic.tid:328": {
    "id": "civic.tid:328",
    "label": "Melphalan",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:6718",
          "label": "melphalan"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:633",
              "type": "Disease",
              "label": "Multiple myeloma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3242"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:645",
              "type": "Disease",
              "label": "Ovarian cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7431"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C633"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-[bis(2-chloroethyl)amino]-L-phenylalanine",
      "Alanine Nitrogen Mustard",
      "CB-3025",
      "L-PAM",
      "L-Phenylalanine Mustard",
      "L-Sarcolysin",
      "L-Sarcolysin Phenylalanine Mustard",
      "L-Sarcolysine",
      "Melphalanum",
      "P-di(chloroethyl)amino-L-phenylalanine",
      "Phenylalanine Mustard",
      "Phenylalanine Nitrogen Mustard",
      "Sarcoclorin",
      "Sarkolysin",
      "WR-19813"
    ]
  },
  "civic.tid:11": {
    "id": "civic.tid:11",
    "label": "Temozolomide",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:37776",
          "label": "temozolomide"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:604",
              "type": "Disease",
              "label": "Glioblastoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3058"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:559",
              "type": "Disease",
              "label": "Anaplastic glioma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C127816"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C1244"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide",
      "8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one",
      "CCRG-81045",
      "Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-",
      "M & B 39831",
      "M And B 39831",
      "Methazolastone",
      "RP-46161",
      "SCH 52365",
      "TMZ",
      "Temcad",
      "Temodal",
      "Temodar",
      "Temomedac"
    ]
  },
  "civic.tid:454": {
    "id": "civic.tid:454",
    "label": "Ivosidenib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2049873",
          "label": "ivosidenib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:580",
              "type": "Disease",
              "label": "Cholangiocarcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4436"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:552",
              "type": "Disease",
              "label": "Acute myeloid leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3171"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C114383"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AG-120",
      "Tibsovo"
    ]
  },
  "civic.ctid:8e8qOIfzxekUHTOw_hUntYTTmid3PG3R": {
    "id": "civic.ctid:8e8qOIfzxekUHTOw_hUntYTTmid3PG3R",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:429",
        "label": "Palbociclib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1601374",
              "label": "palbociclib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C49176"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-one",
          "Ibrance",
          "PD 0332991",
          "PD 332991",
          "PD 991",
          "PD-0332991",
          "Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)-"
        ]
      },
      {
        "id": "civic.tid:375",
        "label": "Letrozole",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:72965",
              "label": "letrozole"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1527"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4,4'-(1H-1,2,4triazol-1-ylmethylene)dibenzonitrile",
          "CGS 20267",
          "Femara"
        ]
      }
    ]
  },
  "civic.tid:537": {
    "id": "civic.tid:537",
    "label": "Imatinib Mesylate",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:282388",
          "label": "imatinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:669",
              "type": "Disease",
              "label": "Systemic mastocytosis",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9235"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:582",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3174"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:24309",
              "type": "Disease",
              "label": "Acute lymphoblastic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3167"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:634",
              "type": "Disease",
              "label": "Myelodysplastic syndrome",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3247"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:602",
              "type": "Disease",
              "label": "Gastrointestinal stromal tumor",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3868"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:33893",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia pediatric"
            },
            {
              "id": "hemonc:667",
              "type": "Disease",
              "label": "Soft tissue sarcoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9306"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:616",
              "type": "Disease",
              "label": "Hypereosinophilic syndrome",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C27038"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C1687"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide Monomethanesulfonate",
      "CGP 57148",
      "CGP57148B",
      "Gleevec",
      "Glivec",
      "STI 571",
      "STI-571",
      "STI571"
    ]
  },
  "civic.tid:28": {
    "id": "civic.tid:28",
    "label": "Panitumumab",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:263034",
          "label": "panitumumab"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D015179",
              "type": "Disease",
              "label": "Colorectal Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2956"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C1857"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "ABX-EGF",
      "ABX-EGF Monoclonal Antibody",
      "ABX-EGF, Clone E7.6.3",
      "E7.6.3",
      "Human IgG2K Monoclonal Antibody",
      "MoAb ABX-EGF",
      "MoAb E7.6.3",
      "Monoclonal Antibody ABX-EGF",
      "Monoclonal Antibody E7.6.3",
      "Vectibix"
    ]
  },
  "civic.tid:431": {
    "id": "civic.tid:431",
    "label": "Rucaparib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1862579",
          "label": "rucaparib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C137800"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-Fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)-",
      "8-Fluoro-2-(4-((methylamino)methyl)phenyl)-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd)indol-6-one"
    ]
  },
  "civic.tid:20": {
    "id": "civic.tid:20",
    "label": "Dasatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1546019",
          "label": "dasatinib anhydrous"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:582",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3174"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:24309",
              "type": "Disease",
              "label": "Acute lymphoblastic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3167"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C38713"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-, Monohydrate",
      "BMS-354825",
      "Dasatinib Hydrate",
      "Dasatinib Monohydrate",
      "Sprycel"
    ]
  },
  "civic.tid:190": {
    "id": "civic.tid:190",
    "label": "Vismodegib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1242987",
          "label": "vismodegib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:587",
              "type": "Disease",
              "label": "Cutaneous basal cell carcinoma"
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C74038"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide",
      "Erivedge",
      "GDC-0449",
      "Hedgehog Antagonist GDC-0449"
    ]
  },
  "civic.tid:138": {
    "id": "civic.tid:138",
    "label": "Pembrolizumab",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1547545",
          "label": "pembrolizumab"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D008545",
              "type": "Disease",
              "label": "Melanoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3224"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C106432"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Immunoglobulin G4, Anti-(Human Programmed Cell Death 1); Humanized Mouse Monoclonal (228-L-proline(H10-S>P))gamma 4 Heavy Chain (134-218')-disulfide With Humanized Mouse Monoclonal Kappa Light Chain Dimer (226-226'':229-229'')-bisdisulfide",
      "Keytruda",
      "Lambrolizumab",
      "MK-3475",
      "SCH 900475"
    ]
  },
  "civic.tid:41": {
    "id": "civic.tid:41",
    "label": "Everolimus",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:141704",
          "label": "everolimus"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:641",
              "type": "Disease",
              "label": "Neuroendocrine tumor",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3809"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:647",
              "type": "Disease",
              "label": "Pancreatic NET",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C27720"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:660",
              "type": "Disease",
              "label": "Renal cell carcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9385"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:45070",
              "type": "Disease",
              "label": "Subependymal giant cell astrocytoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3696"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C48387"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone",
      "42-O-(2-Hydroxy)ethyl Rapamycin",
      "Afinitor",
      "Certican",
      "RAD 001",
      "RAD001",
      "Votubia",
      "Zortress"
    ]
  },
  "civic.tid:273": {
    "id": "civic.tid:273",
    "label": "Futuximab/Modotuximab Mixture",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C91381",
          "label": "Futuximab/Modotuximab Mixture"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C91381"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Anti-EGFR Monoclonal Antibody Mixture Sym004",
      "Futuximab/Modotuximab",
      "Futuximab/Zatuximab",
      "Sym004"
    ]
  },
  "civic.tid:386": {
    "id": "civic.tid:386",
    "label": "Ruxolitinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1193326",
          "label": "ruxolitinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:605",
              "type": "Disease",
              "label": "Graft versus host disease",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3063"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:655",
              "type": "Disease",
              "label": "Polycythemia vera",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3336"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:635",
              "type": "Disease",
              "label": "Myelofibrosis",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3248"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C77888"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(3R)-3-cyclopentyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile",
      "INCB-18424",
      "INCB18424",
      "Jakafi",
      "Oral JAK Inhibitor INCB18424"
    ]
  },
  "civic.tid:63": {
    "id": "civic.tid:63",
    "label": "Selumetinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2289380",
          "label": "selumetinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": []
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C66939"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "ARRY-142886",
      "AZD6244",
      "MEK Inhibitor AZD6244"
    ]
  },
  "civic.tsgid:SunT6HNOnWd9x4jZqzCZjdlnGffyGYUE": {
    "id": "civic.tsgid:SunT6HNOnWd9x4jZqzCZjdlnGffyGYUE",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:423",
        "label": "Cixutumumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C79828",
              "label": "Cixutumumab"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C79828"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Anti-IGF-1R Recombinant Monoclonal Antibody IMC-A12",
          "IMC-A12"
        ]
      },
      {
        "id": "civic.tid:246",
        "label": "Teprotumumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C95797",
              "label": "Teprotumumab"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C95797"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Anti-IGF-1R Monoclonal Antibody R1507",
          "Immunoglobulin G1, Anti-(Human Insulin-like Growth Factor I Receptor)(Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer",
          "R1507",
          "RG1507",
          "RO4858696-000",
          "RV001 Monoclonal"
        ]
      }
    ]
  },
  "civic.tid:425": {
    "id": "civic.tid:425",
    "label": "Savolitinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C104732",
          "label": "Savolitinib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C104732"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AZD 6094",
      "AZD6094",
      "HMPL-504",
      "Volitinib"
    ]
  },
  "civic.ctid:MS46Knve6PfTIRC46pX9lhYnFP_VBKim": {
    "id": "civic.ctid:MS46Knve6PfTIRC46pX9lhYnFP_VBKim",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:543",
        "label": "Checkpoint Kinase Inhibitor AZD7762",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C66961",
              "label": "Checkpoint Kinase Inhibitor AZD7762"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C66961"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AZD-7762",
          "AZD7762"
        ]
      },
      {
        "id": "civic.tid:101",
        "label": "Irinotecan",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:153329",
              "label": "irinotecan hydrochloride"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:46096",
                  "type": "Disease",
                  "label": "Colorectal cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4978"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62040"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(+)-(4S)-4,11-diethyl-4-hydroxy-9-[(4-piperidino-piperidino)carbonyloxy]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinol-3,14,(4H,12H)-dione",
          "(+)-7-ethyl-10-hydroxycamptothecine 10-[1,4'-bipiperidine]-1'-carboxylate",
          "7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin",
          "[1,4'-bipiperidine]-1'-carboxylic Acid (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl Ester"
        ]
      }
    ]
  },
  "civic.tid:159": {
    "id": "civic.tid:159",
    "label": "Ceritinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1535457",
          "label": "ceritinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C115112"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2,4-Pyrimidinediamine, 5-chloro-N4-(2-((1-methylethyl)sulfonyl)phenyl)-N2-(5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl)-",
      "LDK 378",
      "LDK378",
      "Zykadia"
    ]
  },
  "civic.ctid:jmoytbxOWt7JafXnPYxjtvnXiTGnD2uf": {
    "id": "civic.ctid:jmoytbxOWt7JafXnPYxjtvnXiTGnD2uf",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:20",
        "label": "Dasatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1546019",
              "label": "dasatinib anhydrous"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C38713"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-, Monohydrate",
          "BMS-354825",
          "Dasatinib Hydrate",
          "Dasatinib Monohydrate",
          "Sprycel"
        ]
      },
      {
        "id": "civic.tid:15",
        "label": "Erlotinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:337525",
              "label": "erlotinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:648",
                  "type": "Disease",
                  "label": "Pancreatic cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C43298"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C65530"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent"
      }
    ]
  },
  "civic.ctid:gLfpmiZeKZhOgi_mvPUVi0MB2VBYSsjd": {
    "id": "civic.ctid:gLfpmiZeKZhOgi_mvPUVi0MB2VBYSsjd",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:15",
        "label": "Erlotinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:337525",
              "label": "erlotinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:648",
                  "type": "Disease",
                  "label": "Pancreatic cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C43298"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C65530"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent"
      },
      {
        "id": "civic.tid:156",
        "label": "Pemetrexed",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282443",
              "label": "pemetrexed disodium"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:25309",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer nonsquamous"
                },
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C61614"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "L-Glutamic Acid, N-(4-(2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)",
          "MTA",
          "Multitargeted Antifolate",
          "Pemfexy"
        ]
      }
    ]
  },
  "civic.tid:42": {
    "id": "civic.tid:42",
    "label": "Olaparib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1597582",
          "label": "olaparib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:645",
              "type": "Disease",
              "label": "Ovarian cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7431"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:648",
              "type": "Disease",
              "label": "Pancreatic cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C43298"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:658",
              "type": "Disease",
              "label": "Prostate cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7378"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C71721"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AZD 2281",
      "AZD-2281",
      "AZD2281",
      "KU-0059436",
      "Lynparza",
      "PARP Inhibitor AZD2281"
    ]
  },
  "civic.tid:145": {
    "id": "civic.tid:145",
    "label": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C2167",
          "label": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C2167"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:120": {
    "id": "civic.tid:120",
    "label": "Idelalisib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1544460",
          "label": "idelalisib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:599",
              "type": "Disease",
              "label": "Follicular lymphoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3209"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:581",
              "type": "Disease",
              "label": "Chronic lymphocytic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3163"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C78825"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H- Quinazolin-4-one",
      "CAL-101",
      "GS 1101",
      "GS-1101",
      "Phosphoinositide-3 Kinase Delta Inhibitor CAL-101",
      "Zydelig"
    ]
  },
  "civic.ctid:nk5jSUmDAbqS51d-Wm-vj2BlH0T_HAyq": {
    "id": "civic.ctid:nk5jSUmDAbqS51d-Wm-vj2BlH0T_HAyq",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:16",
        "label": "Cetuximab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:318341",
              "label": "cetuximab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D006258",
                  "type": "Disease",
                  "label": "Head and Neck Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4013"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002294",
                  "type": "Disease",
                  "label": "Carcinoma, Squamous Cell",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2929"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1723"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Cetuximab Biosimilar CDP-1",
          "Cetuximab Biosimilar CMAB009",
          "Cetuximab Biosimilar KL 140",
          "Chimeric Anti-EGFR Monoclonal Antibody",
          "Chimeric MoAb C225",
          "Chimeric Monoclonal Antibody C225",
          "Erbitux",
          "IMC-C225"
        ]
      },
      {
        "id": "civic.tid:469",
        "label": "Sirolimus",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:35302",
              "label": "sirolimus"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:37829",
                  "type": "Disease",
                  "label": "PEComa",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C38150"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1212"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,2",
          "AY 22989",
          "RAPA",
          "RAPAMYCIN",
          "Rapamune",
          "SILA 9268A",
          "WY-090217"
        ]
      }
    ]
  },
  "civic.tid:12": {
    "id": "civic.tid:12",
    "label": "Crizotinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1148495",
          "label": "crizotinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:25958",
              "type": "Disease",
              "label": "Anaplastic large cell lymphoma pediatric"
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C74061"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(R)-3-(1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy)-5-(1-(Piperidin-4-Yl)-1h-Pyrazol-4-Yl)Pyridin-2-Amine",
      "2-Pyridinamine, 3-((1R)-1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy)-5-(1-(4-Piperidinyl)-1H-Pyrazol-4-yl)-",
      "MET Tyrosine Kinase Inhibitor PF-02341066",
      "PF-02341066",
      "PF-2341066",
      "Xalkori"
    ]
  },
  "civic.ctid:1u3GKJEPeqRgZXTAhLQ3qlT5HZt4jdzH": {
    "id": "civic.ctid:1u3GKJEPeqRgZXTAhLQ3qlT5HZt4jdzH",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:22",
        "label": "Dabrafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1424911",
              "label": "dabrafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:675",
                  "type": "Disease",
                  "label": "Thyroid cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7510"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C82386"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BRAF Inhibitor GSK2118436",
          "Benzenesulfonamide, N-(3-(5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl)-2-fluorophenyl)-2,6-difluoro-",
          "GSK-2118436",
          "GSK-2118436A",
          "GSK2118436"
        ]
      },
      {
        "id": "civic.tid:19",
        "label": "Trametinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1425098",
              "label": "trametinib dimethyl sulfoxide"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C77908"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "GSK1120212",
          "JTP-74057",
          "MEK Inhibitor GSK1120212",
          "Mekinist",
          "N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide"
        ]
      },
      {
        "id": "civic.tid:4",
        "label": "Vemurafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1147220",
              "label": "vemurafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:594",
                  "type": "Disease",
                  "label": "Erdheim-Chester disease",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C53972"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C64768"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
          "BRAF (V600E) Kinase Inhibitor RO5185426",
          "BRAF(V600E) Kinase Inhibitor RO5185426",
          "PLX-4032",
          "PLX4032",
          "RG 7204",
          "RG7204",
          "RO 5185426",
          "Zelboraf"
        ]
      }
    ]
  },
  "civic.tid:350": {
    "id": "civic.tid:350",
    "label": "MEK Inhibitor TAK-733",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C84858",
          "label": "MEK Inhibitor TAK-733"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C84858"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "TAK-733"
    ]
  },
  "civic.tid:685": {
    "id": "civic.tid:685",
    "label": "Therapeutic Tumor Infiltrating Lymphocytes",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C28699",
          "label": "Therapeutic Tumor Infiltrating Lymphocytes"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C28699"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Tumor Infiltrating Lymphocyte Therapy",
      "Tumor Infiltrating Lymphocytes"
    ]
  },
  "civic.ctid:E39_bNJqxD2YlQvEbnaYPTYj7A6sKF3V": {
    "id": "civic.ctid:E39_bNJqxD2YlQvEbnaYPTYj7A6sKF3V",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:16",
        "label": "Cetuximab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:318341",
              "label": "cetuximab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D006258",
                  "type": "Disease",
                  "label": "Head and Neck Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4013"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002294",
                  "type": "Disease",
                  "label": "Carcinoma, Squamous Cell",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2929"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1723"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Cetuximab Biosimilar CDP-1",
          "Cetuximab Biosimilar CMAB009",
          "Cetuximab Biosimilar KL 140",
          "Chimeric Anti-EGFR Monoclonal Antibody",
          "Chimeric MoAb C225",
          "Chimeric Monoclonal Antibody C225",
          "Erbitux",
          "IMC-C225"
        ]
      },
      {
        "id": "civic.tid:101",
        "label": "Irinotecan",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:153329",
              "label": "irinotecan hydrochloride"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:46096",
                  "type": "Disease",
                  "label": "Colorectal cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4978"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62040"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(+)-(4S)-4,11-diethyl-4-hydroxy-9-[(4-piperidino-piperidino)carbonyloxy]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinol-3,14,(4H,12H)-dione",
          "(+)-7-ethyl-10-hydroxycamptothecine 10-[1,4'-bipiperidine]-1'-carboxylate",
          "7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin",
          "[1,4'-bipiperidine]-1'-carboxylic Acid (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl Ester"
        ]
      }
    ]
  },
  "civic.ctid:iX4s_CHRa8HCapUK6uTigtUxYo5IMhyU": {
    "id": "civic.ctid:iX4s_CHRa8HCapUK6uTigtUxYo5IMhyU",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:326",
        "label": "Cisplatin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2555",
              "label": "cisplatin"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:671",
                  "type": "Disease",
                  "label": "Testicular cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C5053"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:645",
                  "type": "Disease",
                  "label": "Ovarian cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7431"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:569",
                  "type": "Disease",
                  "label": "Bladder cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9334"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C376"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(SP-4-2)-Diamminedichloroplatinum",
          "Abiplatin",
          "Blastolem",
          "Briplatin",
          "CDDP",
          "Cis-diammine-dichloroplatinum",
          "Cis-diamminedichloridoplatinum",
          "Cis-diamminedichloro Platinum (II)",
          "Cis-diamminedichloroplatinum",
          "Cis-dichloroammine Platinum (II)",
          "Cis-platinous Diamine Dichloride",
          "Cis-platinum",
          "Cis-platinum II",
          "Cis-platinum II Diamine Dichloride",
          "Cismaplat",
          "Cisplatina",
          "Cisplatinum",
          "Cisplatyl",
          "Citoplatino",
          "Citosin",
          "Cysplatyna",
          "DDP",
          "Lederplatin",
          "Metaplatin",
          "Neoplatin",
          "Peyrone's Chloride",
          "Peyrone's Salt",
          "Placis",
          "Plastistil",
          "Platamine",
          "Platiblastin",
          "Platiblastin-S",
          "Platinex",
          "Platinol",
          "Platinol- AQ",
          "Platinol-AQ",
          "Platinol-AQ VHA Plus",
          "Platinoxan",
          "Platinum",
          "Platinum Diamminodichloride",
          "Platinum, Diaminedichloro-, Cis- (8CI)",
          "Platiran",
          "Platistin",
          "Platosin"
        ]
      },
      {
        "id": "civic.tid:500",
        "label": "Etoposide",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:4179",
              "label": "etoposide"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:671",
                  "type": "Disease",
                  "label": "Testicular cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C5053"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:666",
                  "type": "Disease",
                  "label": "Small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4917"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C491"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4'-Demethylepipodophyllotoxin 9-[4,6-O-ethylidene-beta-D-glucopyranoside]",
          "9-[(4,6-O-Ethylidene-beta-D-glucopyranosyl]oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one",
          "Demethyl Epipodophyllotoxin Ethylidine Glucoside",
          "EPEG",
          "Lastet",
          "Toposar",
          "VP 16",
          "VP 16-213",
          "VP-16",
          "VP-16-213",
          "VP16",
          "Vepesid"
        ]
      },
      {
        "id": "civic.tid:325",
        "label": "Mitomycin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:632",
              "label": "mitomycin"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": []
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1820"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(1aS,8S,8aR,8bS)-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione",
          "Ametycine",
          "Jelmyto",
          "MITO",
          "MITO-C",
          "MITOMYCIN C",
          "Mito-Medac",
          "Mitocin",
          "Mitocin-C",
          "Mitolem",
          "Mitomycin-C",
          "Mitomycin-X",
          "Mitomycine C",
          "Mitosol",
          "Mitozytrex",
          "Mutamycin",
          "Mutamycine",
          "NCI-C04706",
          "[1aS-(1a Alpha,8beta,8a Alpha,8b Alpha)]-6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione"
        ]
      }
    ]
  },
  "civic.tid:426": {
    "id": "civic.tid:426",
    "label": "Entrectinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2197862",
          "label": "entrectinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": []
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C114984"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "N-(5-(3,5-Difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide",
      "RXDX 101",
      "RXDX-101",
      "RXDX101",
      "Rozlytrek"
    ]
  },
  "civic.ctid:7VqT9zshKTBhH6t4et38ItzQoh3_XLuc": {
    "id": "civic.ctid:7VqT9zshKTBhH6t4et38ItzQoh3_XLuc",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:84",
        "label": "Trastuzumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2103478",
              "label": "trastuzumab-dkst"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D001943",
                  "type": "Disease",
                  "label": "Breast Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2910"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1647"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABP 980",
          "ALT02",
          "Anti-ERB-2",
          "Anti-HER2/c-erbB2 Monoclonal Antibody",
          "Anti-c-ERB-2",
          "Anti-c-erbB2 Monoclonal Antibody",
          "Anti-erbB-2",
          "Anti-erbB2 Monoclonal Antibody",
          "Anti-p185-HER2",
          "C-erb-2 Monoclonal Antibody",
          "HER2 Monoclonal Antibody",
          "Herceptin",
          "Herceptin Biosimilar PF-05280014",
          "Herceptin Trastuzumab Biosimilar PF-05280014",
          "Herzuma",
          "Immunoglobulin G 1 (Human-Mouse Monoclonal RhuMab HER2gamma1-Chain Antihuman P185(Sup C-erbB2) Receptor), Disulfide With Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer",
          "Kanjinti",
          "MoAb HER2",
          "Monoclonal Antibody C-erb-2",
          "Monoclonal Antibody HER2",
          "Ogivri",
          "Ontruzant",
          "PF-05280014",
          "RO0452317",
          "RhuMAb HER2",
          "SB3",
          "Trastuzumab Biosimilar ABP 980",
          "Trastuzumab Biosimilar ALT02",
          "Trastuzumab Biosimilar EG12014",
          "Trastuzumab Biosimilar HLX02",
          "Trastuzumab Biosimilar PF-05280014",
          "Trastuzumab Biosimilar SB3",
          "Trastuzumab Biosimilar SIBP-01",
          "Trastuzumab-anns",
          "Trastuzumab-dkst",
          "Trastuzumab-dttb",
          "Trastuzumab-pkrb",
          "Trastuzumab-qyyp",
          "Trazimera"
        ]
      },
      {
        "id": "civic.tid:531",
        "label": "Leucovorin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:225852",
              "label": "leucovorin calcium"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:46096",
                  "type": "Disease",
                  "label": "Colorectal cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4978"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C71631"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "5-Formyltetrahydrofolate",
          "Folinic Acid"
        ]
      },
      {
        "id": "civic.tid:420",
        "label": "Fluorouracil",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:4492",
              "label": "fluorouracil"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": []
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C505"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "2,4-Dioxo-5-fluoropyrimidine",
          "5 FU",
          "5 Fluorouracil",
          "5 Fluorouracilum",
          "5-FU",
          "5-Fluoro-2,4(1H, 3H)-pyrimidinedione",
          "5-Fluoro-2,4(1H,3H)-pyrimidinedione",
          "5-Fluorouracil",
          "5-Fluracil",
          "5FU",
          "AccuSite",
          "Adrucil",
          "Carac",
          "Fluoro Uracil",
          "Fluouracil",
          "Flurablastin",
          "Fluracedyl",
          "Fluracil",
          "Fluril",
          "Fluroblastin",
          "Ribofluor",
          "Ro 2-9757",
          "Ro-2-9757"
        ]
      }
    ]
  },
  "civic.ctid:keEkpEukYHqb30iQi2psXXZ3Lz1wK7-2": {
    "id": "civic.ctid:keEkpEukYHqb30iQi2psXXZ3Lz1wK7-2",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:4",
        "label": "Vemurafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1147220",
              "label": "vemurafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:594",
                  "type": "Disease",
                  "label": "Erdheim-Chester disease",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C53972"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C64768"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
          "BRAF (V600E) Kinase Inhibitor RO5185426",
          "BRAF(V600E) Kinase Inhibitor RO5185426",
          "PLX-4032",
          "PLX4032",
          "RG 7204",
          "RG7204",
          "RO 5185426",
          "Zelboraf"
        ]
      },
      {
        "id": "civic.tid:28",
        "label": "Panitumumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:263034",
              "label": "panitumumab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1857"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABX-EGF",
          "ABX-EGF Monoclonal Antibody",
          "ABX-EGF, Clone E7.6.3",
          "E7.6.3",
          "Human IgG2K Monoclonal Antibody",
          "MoAb ABX-EGF",
          "MoAb E7.6.3",
          "Monoclonal Antibody ABX-EGF",
          "Monoclonal Antibody E7.6.3",
          "Vectibix"
        ]
      },
      {
        "id": "civic.tid:101",
        "label": "Irinotecan",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:153329",
              "label": "irinotecan hydrochloride"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:46096",
                  "type": "Disease",
                  "label": "Colorectal cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4978"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62040"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(+)-(4S)-4,11-diethyl-4-hydroxy-9-[(4-piperidino-piperidino)carbonyloxy]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinol-3,14,(4H,12H)-dione",
          "(+)-7-ethyl-10-hydroxycamptothecine 10-[1,4'-bipiperidine]-1'-carboxylate",
          "7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin",
          "[1,4'-bipiperidine]-1'-carboxylic Acid (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl Ester"
        ]
      }
    ]
  },
  "civic.ctid:QjxndwLs8w8D3pJIekSdxyQ8LOHQSIF_": {
    "id": "civic.ctid:QjxndwLs8w8D3pJIekSdxyQ8LOHQSIF_",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:4",
        "label": "Vemurafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1147220",
              "label": "vemurafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:594",
                  "type": "Disease",
                  "label": "Erdheim-Chester disease",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C53972"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C64768"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
          "BRAF (V600E) Kinase Inhibitor RO5185426",
          "BRAF(V600E) Kinase Inhibitor RO5185426",
          "PLX-4032",
          "PLX4032",
          "RG 7204",
          "RG7204",
          "RO 5185426",
          "Zelboraf"
        ]
      },
      {
        "id": "civic.tid:247",
        "label": "Pertuzumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1298944",
              "label": "pertuzumab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D001943",
                  "type": "Disease",
                  "label": "Breast Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2910"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C38692"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "2C4",
          "2C4 Antibody",
          "HS627",
          "Immunoglobulin G1, Anti-(Human V (Receptor)) (Human-Mouse Monoclonal 2C4 Heavy Chain), Disulfide With Human-Mouse Monoclonal 2C4 Kappa-Chain, Dimer",
          "MoAb 2C4",
          "Monoclonal Antibody 2C4",
          "Omnitarg",
          "Perjeta",
          "Pertuzumab Biosimilar HS627",
          "RO4368451",
          "RhuMAb2C4"
        ]
      }
    ]
  },
  "civic.tid:601": {
    "id": "civic.tid:601",
    "label": "Selpercatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2370147",
          "label": "selpercatinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:675",
              "type": "Disease",
              "label": "Thyroid cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7510"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C134987"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo(3.1.1)heptan-3-yl)pyridin-3-yl)pyrazolo(1,5-a)pyridine-3-carbonitril",
      "LOXO-292",
      "RET Inhibitor LOXO-292",
      "RET Kinase Inhibitor LOXO-292",
      "Retevmo",
      "WHO 10967"
    ]
  },
  "civic.tid:699": {
    "id": "civic.tid:699",
    "label": "BRAF Inhibitor",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C155322",
          "label": "BRAF Inhibitor"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C155322"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "B-RAF Inhibitor"
    ]
  },
  "civic.ctid:DL-rzLeUUdAwgqhOo4lMSKVLq4CR4E9_": {
    "id": "civic.ctid:DL-rzLeUUdAwgqhOo4lMSKVLq4CR4E9_",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:699",
        "label": "BRAF Inhibitor",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C155322",
              "label": "BRAF Inhibitor"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C155322"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "B-RAF Inhibitor"
        ]
      },
      {
        "id": "civic.tid:110",
        "label": "Mitogen-Activated Protein Kinase Kinase Inhibitor",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C69145",
              "label": "Mitogen-Activated Protein Kinase Kinase Inhibitor"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C69145"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent"
      }
    ]
  },
  "civic.ctid:mnqlxI5kTjJ6WninClclCU94-Xy_RBfY": {
    "id": "civic.ctid:mnqlxI5kTjJ6WninClclCU94-Xy_RBfY",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:42",
        "label": "Olaparib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1597582",
              "label": "olaparib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:645",
                  "type": "Disease",
                  "label": "Ovarian cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7431"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:648",
                  "type": "Disease",
                  "label": "Pancreatic cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C43298"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:658",
                  "type": "Disease",
                  "label": "Prostate cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7378"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C71721"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AZD 2281",
          "AZD-2281",
          "AZD2281",
          "KU-0059436",
          "Lynparza",
          "PARP Inhibitor AZD2281"
        ]
      },
      {
        "id": "civic.tid:11",
        "label": "Temozolomide",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:37776",
              "label": "temozolomide"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:604",
                  "type": "Disease",
                  "label": "Glioblastoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3058"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:559",
                  "type": "Disease",
                  "label": "Anaplastic glioma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C127816"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1244"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide",
          "8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one",
          "CCRG-81045",
          "Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-",
          "M & B 39831",
          "M And B 39831",
          "Methazolastone",
          "RP-46161",
          "SCH 52365",
          "TMZ",
          "Temcad",
          "Temodal",
          "Temodar",
          "Temomedac"
        ]
      }
    ]
  },
  "civic.tid:56": {
    "id": "civic.tid:56",
    "label": "Pazopanib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:714438",
          "label": "pazopanib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C74547"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-",
      "GW786034"
    ]
  },
  "civic.tid:1975": {
    "id": "civic.tid:1975",
    "label": "Pemigatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2359268",
          "label": "pemigatinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:580",
              "type": "Disease",
              "label": "Cholangiocarcinoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4436"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C121553"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2H-Pyrrolo(3',2':5,6)pyrido(4,3-d)pyrimidin-2-one, 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-1,3,4,7-tetrahydro-8-(4-morpholinylmethyl)-",
      "INCB054828",
      "Pemazyre"
    ]
  },
  "civic.tid:10": {
    "id": "civic.tid:10",
    "label": "Tanespimycin",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C37899",
          "label": "Tanespimycin"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C37899"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "17-(Allylamino)-17-demethoxygeldanamycin",
      "17-AAG",
      "17-Allylamino-17-demethoxygeldanamycin",
      "17-Demethoxy-17-(2-propenylamino)geldanamycin",
      "17-N-allylamino-17-demethoxy Geldanamycin",
      "17-N-allylamino-17-demethoxygeldanamycin",
      "Geldanamycin, 17-allylamino-17-demethoxy-",
      "KOS-953"
    ]
  },
  "civic.tid:141": {
    "id": "civic.tid:141",
    "label": "Pictilisib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C165479",
          "label": "Pictilisib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C165479"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-(1H-indazol-4-yl)-6-((4-(methanesulfonyl)piperazin-1-yl)methyl)-4-(morpholin-4-yl)thieno(3,2-d)pyrimidine",
      "4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno(3,2-d)pyrimidin-4-yl)morpholine",
      "GDC 0941",
      "GDC-0941",
      "GDC0941"
    ]
  },
  "civic.tid:148": {
    "id": "civic.tid:148",
    "label": "Abemaciclib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1946825",
          "label": "abemaciclib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C97660"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-Pyrimidinamine, N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)",
      "LY-2835219",
      "LY2835219",
      "Verzenio"
    ]
  },
  "civic.tid:43": {
    "id": "civic.tid:43",
    "label": "Akt Inhibitor MK2206",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C90581",
          "label": "Akt Inhibitor MK2206"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C90581"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1,2,4-Triazolo(3,4-f)(1,6)naphthyridin-3(2H)-one, 8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl-",
      "MK 2206",
      "MK-2206",
      "MK-2206 FREE BASE",
      "MK2206"
    ]
  },
  "civic.tid:377": {
    "id": "civic.tid:377",
    "label": "Apitolisib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C91731",
          "label": "Apitolisib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C91731"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "GDC 0980",
      "GDC-0980",
      "GNE 390",
      "RG 7422"
    ]
  },
  "civic.ctid:hAKRvUsYco9D9KhfWrgO7JE2mcctWJ0Y": {
    "id": "civic.ctid:hAKRvUsYco9D9KhfWrgO7JE2mcctWJ0Y",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:41",
        "label": "Everolimus",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:141704",
              "label": "everolimus"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:641",
                  "type": "Disease",
                  "label": "Neuroendocrine tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3809"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:647",
                  "type": "Disease",
                  "label": "Pancreatic NET",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27720"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:45070",
                  "type": "Disease",
                  "label": "Subependymal giant cell astrocytoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3696"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C48387"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone",
          "42-O-(2-Hydroxy)ethyl Rapamycin",
          "Afinitor",
          "Certican",
          "RAD 001",
          "RAD001",
          "Votubia",
          "Zortress"
        ]
      },
      {
        "id": "civic.tid:54",
        "label": "Fulvestrant",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282357",
              "label": "fulvestrant"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1379"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "7a-[9-[(4,4,5,5,5,-Pentafluoropentyl)sulphinyl]nonyl]-estra-1,3,5(10)-triene-3,17b-diol",
          "Faslodex",
          "Faslodex(ICI 182,780)",
          "ICI 182,780",
          "ICI 182780",
          "ZD9238"
        ]
      }
    ]
  },
  "civic.ctid:-TUOzS0ClpVaUo5oisn2Bt0H0ZHPi1cJ": {
    "id": "civic.ctid:-TUOzS0ClpVaUo5oisn2Bt0H0ZHPi1cJ",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:16",
        "label": "Cetuximab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:318341",
              "label": "cetuximab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D006258",
                  "type": "Disease",
                  "label": "Head and Neck Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4013"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002294",
                  "type": "Disease",
                  "label": "Carcinoma, Squamous Cell",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2929"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1723"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Cetuximab Biosimilar CDP-1",
          "Cetuximab Biosimilar CMAB009",
          "Cetuximab Biosimilar KL 140",
          "Chimeric Anti-EGFR Monoclonal Antibody",
          "Chimeric MoAb C225",
          "Chimeric Monoclonal Antibody C225",
          "Erbitux",
          "IMC-C225"
        ]
      },
      {
        "id": "civic.tid:237",
        "label": "Oxaliplatin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:32592",
              "label": "oxaliplatin"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:46096",
                  "type": "Disease",
                  "label": "Colorectal cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4978"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:585",
                  "type": "Disease",
                  "label": "Colon cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9242"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1181"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-OHP",
          "Ai Heng",
          "Aiheng",
          "DACPLAT",
          "Dacotin",
          "Diaminocyclohexane Oxalatoplatinum",
          "ELOXATIN",
          "Eloxatine",
          "JM-83",
          "Oxalato (1R,2R-cyclohexanediamine)platinum(II)",
          "Oxalato (trans-l-1,2-diaminocyclohexane)platinum(II)",
          "Oxalatoplatin",
          "Oxalatoplatinum",
          "RP 54780",
          "RP-54780",
          "SR-96669",
          "Trans-l DACH Oxalatoplatinum",
          "Trans-l Diaminocyclohexane Oxalatoplatinum",
          "[(1R,-2R)-1,2-cyclohexanediamine-N,N'][oxalato (2--)-O,O']platinum",
          "[SP-4-2-(1R-trans)]-(1,2,cyclohexanediamine-N,N')[ethanedioato(2--)-O,O']platinum"
        ]
      },
      {
        "id": "civic.tid:420",
        "label": "Fluorouracil",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:4492",
              "label": "fluorouracil"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": []
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C505"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "2,4-Dioxo-5-fluoropyrimidine",
          "5 FU",
          "5 Fluorouracil",
          "5 Fluorouracilum",
          "5-FU",
          "5-Fluoro-2,4(1H, 3H)-pyrimidinedione",
          "5-Fluoro-2,4(1H,3H)-pyrimidinedione",
          "5-Fluorouracil",
          "5-Fluracil",
          "5FU",
          "AccuSite",
          "Adrucil",
          "Carac",
          "Fluoro Uracil",
          "Fluouracil",
          "Flurablastin",
          "Fluracedyl",
          "Fluracil",
          "Fluril",
          "Fluroblastin",
          "Ribofluor",
          "Ro 2-9757",
          "Ro-2-9757"
        ]
      }
    ]
  },
  "civic.tid:572": {
    "id": "civic.tid:572",
    "label": "Meloxicam",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:41493",
          "label": "meloxicam"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": []
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C61439"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide",
      "Mobec",
      "Mobic",
      "Mobicox",
      "Movalis",
      "Movatec"
    ]
  },
  "civic.tsgid:jKuLlWRt_pXwz9R2lQrLzMdihFWFZMMK": {
    "id": "civic.tsgid:jKuLlWRt_pXwz9R2lQrLzMdihFWFZMMK",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:5",
        "label": "Imatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282388",
              "label": "imatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:669",
                  "type": "Disease",
                  "label": "Systemic mastocytosis",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9235"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:634",
                  "type": "Disease",
                  "label": "Myelodysplastic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3247"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:33893",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia pediatric"
                },
                {
                  "id": "hemonc:667",
                  "type": "Disease",
                  "label": "Soft tissue sarcoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9306"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:616",
                  "type": "Disease",
                  "label": "Hypereosinophilic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27038"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62035"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide"
        ]
      },
      {
        "id": "civic.tid:20",
        "label": "Dasatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1546019",
              "label": "dasatinib anhydrous"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C38713"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-, Monohydrate",
          "BMS-354825",
          "Dasatinib Hydrate",
          "Dasatinib Monohydrate",
          "Sprycel"
        ]
      }
    ]
  },
  "civic.tsgid:IMgxRLc3XTtFhF3LrdtkdhJqiCh-_3dE": {
    "id": "civic.tsgid:IMgxRLc3XTtFhF3LrdtkdhJqiCh-_3dE",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:87",
        "label": "Thioguanine",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:10485",
              "label": "thioguanine"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": []
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C876"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "2-Amino 6MP",
          "2-Amino-1,7-dihydro-6H-purine-6-thione",
          "2-Amino-6-mercaptopurine",
          "2-Amino-6-purinethiol",
          "2-Aminopurin-6-thiol",
          "2-Aminopurine-6(1H)-thione",
          "2-Aminopurine-6-thiol",
          "2-Aminopurine-6-thiol Hemihydrate",
          "2-Mercapto-6-aminopurine",
          "6 Mercaptoguanine",
          "6 Thioguanine",
          "6-Amino-2-mercaptopurine",
          "6-Mercapto-2-aminopurine",
          "6-Mercaptoguanine",
          "6-TG",
          "6-Thioguanine",
          "6H-Purine-6-thione, 2-amino-1,7-dihydro- (9CI)",
          "BW 5071",
          "Lanvis",
          "Tabloid",
          "Thioguanine Hemihydrate",
          "Thioguanine Hydrate",
          "Tioguanin",
          "Tioguanine",
          "WR-1141",
          "Wellcome U3B",
          "X 27"
        ]
      },
      {
        "id": "civic.tid:86",
        "label": "Mercaptopurine",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:103",
              "label": "mercaptopurine"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C195"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1,7-Dihydro-6H-purine-6-thione",
          "1,7-Dihydro-6H-purine-6-thione Monohydrate",
          "3H-Purine-6-thiol",
          "6 MP",
          "6 Thiohypoxanthine",
          "6 Thiopurine",
          "6-MP",
          "6-Mercaptopurine",
          "6-Mercaptopurine Monohydrate",
          "6-Purinethiol",
          "6-Thiopurine",
          "6-Thioxopurine",
          "6H-Purine-6-thione, 1,7-dihydro- (9CI)",
          "7-Mercapto-1,3,4,6-tetrazaindene",
          "Alti-Mercaptopurine",
          "Azathiopurine",
          "BW 57-323H",
          "Flocofil",
          "Ismipur",
          "Leukerin",
          "Leupurin",
          "Mercaleukim",
          "Mercaleukin",
          "Mercaptina",
          "Mercapto-6-purine",
          "Mercaptopurinum",
          "Mercapurin",
          "Mern",
          "NCI-C04886",
          "Puri-Nethol",
          "Purimethol",
          "Purine, 6-mercapto-",
          "Purine-6-thiol (8CI)",
          "Purine-6-thiol Monohydrate",
          "Purine-6-thiol, Monohydrate",
          "Purinethiol",
          "Purinethol",
          "U-4748",
          "WR-2785"
        ]
      }
    ]
  },
  "civic.tid:574": {
    "id": "civic.tid:574",
    "label": "Venetoclax",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1747556",
          "label": "venetoclax"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:552",
              "type": "Disease",
              "label": "Acute myeloid leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3171"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:581",
              "type": "Disease",
              "label": "Chronic lymphocytic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3163"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C103147"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-(4-((2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide",
      "ABT-0199",
      "ABT-199",
      "ABT199",
      "GDC-0199",
      "RG7601",
      "Venclexta",
      "Venclyxto"
    ]
  },
  "civic.tid:411": {
    "id": "civic.tid:411",
    "label": "Tazemetostat",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2274378",
          "label": "tazemetostat"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": []
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C107506"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "E7438",
      "EPZ-6438",
      "EPZ6438",
      "N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(oxan-4-yl)amino)-4-methyl-4'-((morpholin-4-yl)methyl)(1,1'-biphenyl)-3-carboxamide",
      "N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide"
    ]
  },
  "civic.tid:573": {
    "id": "civic.tid:573",
    "label": "Larotrectinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2105628",
          "label": "larotrectinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:44382",
              "type": "Disease",
              "label": "Malignant solid neoplasm",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C132146"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C115977"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-",
      "3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine- 1-carboxamide",
      "ARRY 470",
      "LOXO 101",
      "LOXO-101"
    ]
  },
  "civic.tid:520": {
    "id": "civic.tid:520",
    "label": "Bosutinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1307619",
          "label": "bosutinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "EFO:0000339",
              "type": "Disease",
              "label": "chronic myelogenous leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3174"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C60809"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-Anilino-3-quinolinecarbonitrile",
      "4-Anilinobenzo(g)quinoline-3-carbonitrile",
      "4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile",
      "Bosulif",
      "SKI 606",
      "SKI-606"
    ]
  },
  "civic.tid:45": {
    "id": "civic.tid:45",
    "label": "Lapatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:480167",
          "label": "lapatinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C26653"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "GSK572016",
      "GW 2016",
      "GW2016",
      "GW572016"
    ]
  },
  "civic.tid:52": {
    "id": "civic.tid:52",
    "label": "Neratinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1940643",
          "label": "neratinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C49094"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(2E)-N-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide",
      "2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-",
      "HKI 272",
      "HKI-272",
      "PB 272",
      "PB-272"
    ]
  },
  "civic.tsgid:bf_BuyNMwaqXScLEAS5F0_LZZf1t1H2f": {
    "id": "civic.tsgid:bf_BuyNMwaqXScLEAS5F0_LZZf1t1H2f",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:52",
        "label": "Neratinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1940643",
              "label": "neratinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C49094"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(2E)-N-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide",
          "2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-",
          "HKI 272",
          "HKI-272",
          "PB 272",
          "PB-272"
        ]
      },
      {
        "id": "civic.tid:45",
        "label": "Lapatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:480167",
              "label": "lapatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C26653"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "GSK572016",
          "GW 2016",
          "GW2016",
          "GW572016"
        ]
      }
    ]
  },
  "civic.tsgid:Dsj0jsyr-fQXgAxQL6jcaLTVy4zoAdvF": {
    "id": "civic.tsgid:Dsj0jsyr-fQXgAxQL6jcaLTVy4zoAdvF",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:53",
        "label": "Tamoxifen",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:10324",
              "label": "tamoxifen"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62078"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene"
        ]
      },
      {
        "id": "civic.tid:54",
        "label": "Fulvestrant",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282357",
              "label": "fulvestrant"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1379"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "7a-[9-[(4,4,5,5,5,-Pentafluoropentyl)sulphinyl]nonyl]-estra-1,3,5(10)-triene-3,17b-diol",
          "Faslodex",
          "Faslodex(ICI 182,780)",
          "ICI 182,780",
          "ICI 182780",
          "ZD9238"
        ]
      }
    ]
  },
  "civic.tsgid:f0IOBQHIv94-aVcb5dMKA9rkPpDFY0jD": {
    "id": "civic.tsgid:f0IOBQHIv94-aVcb5dMKA9rkPpDFY0jD",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:55",
        "label": "Ponatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1364347",
              "label": "ponatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C95777"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AP-24534",
          "AP24534",
          "Benzamide, 3-(2-Imidazo(1,2-B)Pyridazin-3-Ylethynyl)-4-Methyl-N-(4-((4-Methyl-1- Piperazinyl)Methyl)-3-(Trifluoromethyl)Phenyl)"
        ]
      },
      {
        "id": "civic.tid:157",
        "label": "Sunitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:357977",
              "label": "sunitinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:647",
                  "type": "Disease",
                  "label": "Pancreatic NET",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27720"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C71622"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-"
        ]
      }
    ]
  },
  "civic.tid:21": {
    "id": "civic.tid:21",
    "label": "Crenolanib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C64639",
          "label": "Crenolanib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C64639"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "4-Piperidinamine, 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1Hbenzimidazol-1-yl]-8-quinolinyl]-",
      "CP-868,596",
      "CP-868596",
      "PDGFR Inhibitor CP-868596",
      "[1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine"
    ]
  },
  "civic.tid:18": {
    "id": "civic.tid:18",
    "label": "TAE684",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C171615",
          "label": "ALK Inhibitor TAE684"
        }
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.ctid:23p9szOW83imwzdNpS6omDSCucd7VZPf": {
    "id": "civic.ctid:23p9szOW83imwzdNpS6omDSCucd7VZPf",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:63",
        "label": "Selumetinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2289380",
              "label": "selumetinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": []
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C66939"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ARRY-142886",
          "AZD6244",
          "MEK Inhibitor AZD6244"
        ]
      },
      {
        "id": "civic.tid:343",
        "label": "Dactolisib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C74072",
              "label": "Dactolisib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C74072"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BEZ235",
          "Benzeneacetonitrile, 4-(2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo(4,5-c)quinolin-1-yl)-alpha,alpha-dimethyl-",
          "NVPBEZ235"
        ]
      }
    ]
  },
  "civic.tid:66": {
    "id": "civic.tid:66",
    "label": "PI3K-alpha Inhibitor MEN1611",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C158603",
          "label": "Izorlisib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C158603"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "5-(7-Methylsulfonyl-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine",
      "Alpha-selective PI3K Inhibitor MEN1611",
      "CH 5132799",
      "CH-5132799",
      "CH5132799",
      "MEN 1611",
      "MEN-1611",
      "MEN1611",
      "PA 799",
      "PA-799",
      "PA799",
      "PI3Kalpha Inhibitor MEN1611"
    ]
  },
  "civic.tid:67": {
    "id": "civic.tid:67",
    "label": "MTOR Inhibitor",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C2201",
          "label": "mTOR Inhibitor"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C2201"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tsgid:WhfBuE9-X8HJ0XrZkBrvk5szSlPlh2lC": {
    "id": "civic.tsgid:WhfBuE9-X8HJ0XrZkBrvk5szSlPlh2lC",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:163",
        "label": "Enzalutamide",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1307298",
              "label": "enzalutamide"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:658",
                  "type": "Disease",
                  "label": "Prostate cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7378"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C71744"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ASP9785",
          "Benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-",
          "MDV3100",
          "Xtandi"
        ]
      },
      {
        "id": "civic.tid:364",
        "label": "Apalutamide",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1999574",
              "label": "apalutamide"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:658",
                  "type": "Disease",
                  "label": "Prostate cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7378"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C92574"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-(7-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro(3.4)octan-5-yl)-2-fluoro-N-methylbenzamide",
          "ARN 509",
          "ARN-509",
          "ARN509",
          "Erleada",
          "JNJ 56021927",
          "JNJ-56021927"
        ]
      }
    ]
  },
  "civic.tsgid:7UdV-6r5BcGyVPqQkUITkTOl1vZRajMR": {
    "id": "civic.tsgid:7UdV-6r5BcGyVPqQkUITkTOl1vZRajMR",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:4",
        "label": "Vemurafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1147220",
              "label": "vemurafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:594",
                  "type": "Disease",
                  "label": "Erdheim-Chester disease",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C53972"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C64768"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
          "BRAF (V600E) Kinase Inhibitor RO5185426",
          "BRAF(V600E) Kinase Inhibitor RO5185426",
          "PLX-4032",
          "PLX4032",
          "RG 7204",
          "RG7204",
          "RO 5185426",
          "Zelboraf"
        ]
      },
      {
        "id": "civic.tid:22",
        "label": "Dabrafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1424911",
              "label": "dabrafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:675",
                  "type": "Disease",
                  "label": "Thyroid cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7510"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C82386"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BRAF Inhibitor GSK2118436",
          "Benzenesulfonamide, N-(3-(5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl)-2-fluorophenyl)-2,6-difluoro-",
          "GSK-2118436",
          "GSK-2118436A",
          "GSK2118436"
        ]
      }
    ]
  },
  "civic.tid:473": {
    "id": "civic.tid:473",
    "label": "AGI-5198",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "iuphar.ligand:9240",
          "label": "AGI-5198"
        }
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tsgid:DikLqTiUzvlAynTzqBw5f3Cj5Arf5sW1": {
    "id": "civic.tsgid:DikLqTiUzvlAynTzqBw5f3Cj5Arf5sW1",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:273",
        "label": "Futuximab/Modotuximab Mixture",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C91381",
              "label": "Futuximab/Modotuximab Mixture"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C91381"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Anti-EGFR Monoclonal Antibody Mixture Sym004",
          "Futuximab/Modotuximab",
          "Futuximab/Zatuximab",
          "Sym004"
        ]
      },
      {
        "id": "civic.tid:28",
        "label": "Panitumumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:263034",
              "label": "panitumumab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1857"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABX-EGF",
          "ABX-EGF Monoclonal Antibody",
          "ABX-EGF, Clone E7.6.3",
          "E7.6.3",
          "Human IgG2K Monoclonal Antibody",
          "MoAb ABX-EGF",
          "MoAb E7.6.3",
          "Monoclonal Antibody ABX-EGF",
          "Monoclonal Antibody E7.6.3",
          "Vectibix"
        ]
      }
    ]
  },
  "civic.ctid:fhoJlflGcyI7CoY-_bzWLsBwlsn7GwLN": {
    "id": "civic.ctid:fhoJlflGcyI7CoY-_bzWLsBwlsn7GwLN",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:52",
        "label": "Neratinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1940643",
              "label": "neratinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C49094"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(2E)-N-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide",
          "2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-",
          "HKI 272",
          "HKI-272",
          "PB 272",
          "PB-272"
        ]
      },
      {
        "id": "civic.tid:45",
        "label": "Lapatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:480167",
              "label": "lapatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C26653"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "GSK572016",
          "GW 2016",
          "GW2016",
          "GW572016"
        ]
      },
      {
        "id": "civic.tid:84",
        "label": "Trastuzumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2103478",
              "label": "trastuzumab-dkst"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D001943",
                  "type": "Disease",
                  "label": "Breast Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2910"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1647"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABP 980",
          "ALT02",
          "Anti-ERB-2",
          "Anti-HER2/c-erbB2 Monoclonal Antibody",
          "Anti-c-ERB-2",
          "Anti-c-erbB2 Monoclonal Antibody",
          "Anti-erbB-2",
          "Anti-erbB2 Monoclonal Antibody",
          "Anti-p185-HER2",
          "C-erb-2 Monoclonal Antibody",
          "HER2 Monoclonal Antibody",
          "Herceptin",
          "Herceptin Biosimilar PF-05280014",
          "Herceptin Trastuzumab Biosimilar PF-05280014",
          "Herzuma",
          "Immunoglobulin G 1 (Human-Mouse Monoclonal RhuMab HER2gamma1-Chain Antihuman P185(Sup C-erbB2) Receptor), Disulfide With Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer",
          "Kanjinti",
          "MoAb HER2",
          "Monoclonal Antibody C-erb-2",
          "Monoclonal Antibody HER2",
          "Ogivri",
          "Ontruzant",
          "PF-05280014",
          "RO0452317",
          "RhuMAb HER2",
          "SB3",
          "Trastuzumab Biosimilar ABP 980",
          "Trastuzumab Biosimilar ALT02",
          "Trastuzumab Biosimilar EG12014",
          "Trastuzumab Biosimilar HLX02",
          "Trastuzumab Biosimilar PF-05280014",
          "Trastuzumab Biosimilar SB3",
          "Trastuzumab Biosimilar SIBP-01",
          "Trastuzumab-anns",
          "Trastuzumab-dkst",
          "Trastuzumab-dttb",
          "Trastuzumab-pkrb",
          "Trastuzumab-qyyp",
          "Trazimera"
        ]
      }
    ]
  },
  "civic.tid:241": {
    "id": "civic.tid:241",
    "label": "Lorlatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2103164",
          "label": "lorlatinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:642",
              "type": "Disease",
              "label": "Non-small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C2926"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C113655"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2H-4,8-Methenopyrazolo(4,3-H)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-",
      "7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile",
      "Lorbrena",
      "PF-06463922"
    ]
  },
  "civic.tid:469": {
    "id": "civic.tid:469",
    "label": "Sirolimus",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:35302",
          "label": "sirolimus"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:37829",
              "type": "Disease",
              "label": "PEComa",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C38150"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C1212"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,2",
      "AY 22989",
      "RAPA",
      "RAPAMYCIN",
      "Rapamune",
      "SILA 9268A",
      "WY-090217"
    ]
  },
  "civic.tid:124": {
    "id": "civic.tid:124",
    "label": "MTOR Kinase Inhibitor AZD8055",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C78856",
          "label": "mTOR Kinase Inhibitor AZD8055"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C78856"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AZD-8055",
      "AZD8055"
    ]
  },
  "civic.tsgid:YPX4hWBVzOuHhIwr13nNgLhGznlVAIEa": {
    "id": "civic.tsgid:YPX4hWBVzOuHhIwr13nNgLhGznlVAIEa",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:124",
        "label": "MTOR Kinase Inhibitor AZD8055",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C78856",
              "label": "mTOR Kinase Inhibitor AZD8055"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C78856"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AZD-8055",
          "AZD8055"
        ]
      },
      {
        "id": "civic.tid:376",
        "label": "RapaLink-1",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "iuphar.ligand:9212",
              "label": "RapaLink-1"
            }
          }
        ],
        "type": "TherapeuticAgent"
      }
    ]
  },
  "civic.tid:505": {
    "id": "civic.tid:505",
    "label": "Quizartinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C68936",
          "label": "Quizartinib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C68936"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(2E)-N-(4-(3-Chloro-4-Fluoroanilino)-7-(((3S)-Oxolan-3-Yl)Oxy)Quinoxazolin-6-yl)-4-(Dimethylamino)but-2-Enamide",
      "AC-220",
      "AC010220",
      "AC220",
      "N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo [2,1-b] [1,3] Benzothiazol 2-yl]phenyl}urea"
    ]
  },
  "civic.tid:20623": {
    "id": "civic.tid:20623",
    "label": "MDM2 Inhibitor AMGMDS3",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C171616",
          "label": "MDM2 Inhibitor AMGMDS3"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C171616"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-[(2S,3R,4S)-2,3-bis(3-chlorophenyl)-1-[(2S)-1-ethoxy-1-oxobutan-2-yl]-4-methyl-6-oxopiperidin-4-yl]acetic Acid",
      "AMGMDS3",
      "Q59770979"
    ]
  },
  "civic.tsgid:XfIozULZDMYsSPTJsoBBE_VUj4zzkscC": {
    "id": "civic.tsgid:XfIozULZDMYsSPTJsoBBE_VUj4zzkscC",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:5",
        "label": "Imatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282388",
              "label": "imatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:669",
                  "type": "Disease",
                  "label": "Systemic mastocytosis",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9235"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:634",
                  "type": "Disease",
                  "label": "Myelodysplastic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3247"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:33893",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia pediatric"
                },
                {
                  "id": "hemonc:667",
                  "type": "Disease",
                  "label": "Soft tissue sarcoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9306"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:616",
                  "type": "Disease",
                  "label": "Hypereosinophilic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27038"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62035"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide"
        ]
      },
      {
        "id": "civic.tid:157",
        "label": "Sunitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:357977",
              "label": "sunitinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:647",
                  "type": "Disease",
                  "label": "Pancreatic NET",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27720"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C71622"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-"
        ]
      }
    ]
  },
  "civic.ctid:Exy3-S7snfyhQHnOQ6ZbukSAmtGQaYfA": {
    "id": "civic.ctid:Exy3-S7snfyhQHnOQ6ZbukSAmtGQaYfA",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:45",
        "label": "Lapatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:480167",
              "label": "lapatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C26653"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "GSK572016",
          "GW 2016",
          "GW2016",
          "GW572016"
        ]
      },
      {
        "id": "civic.tid:84",
        "label": "Trastuzumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2103478",
              "label": "trastuzumab-dkst"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D001943",
                  "type": "Disease",
                  "label": "Breast Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2910"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1647"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABP 980",
          "ALT02",
          "Anti-ERB-2",
          "Anti-HER2/c-erbB2 Monoclonal Antibody",
          "Anti-c-ERB-2",
          "Anti-c-erbB2 Monoclonal Antibody",
          "Anti-erbB-2",
          "Anti-erbB2 Monoclonal Antibody",
          "Anti-p185-HER2",
          "C-erb-2 Monoclonal Antibody",
          "HER2 Monoclonal Antibody",
          "Herceptin",
          "Herceptin Biosimilar PF-05280014",
          "Herceptin Trastuzumab Biosimilar PF-05280014",
          "Herzuma",
          "Immunoglobulin G 1 (Human-Mouse Monoclonal RhuMab HER2gamma1-Chain Antihuman P185(Sup C-erbB2) Receptor), Disulfide With Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer",
          "Kanjinti",
          "MoAb HER2",
          "Monoclonal Antibody C-erb-2",
          "Monoclonal Antibody HER2",
          "Ogivri",
          "Ontruzant",
          "PF-05280014",
          "RO0452317",
          "RhuMAb HER2",
          "SB3",
          "Trastuzumab Biosimilar ABP 980",
          "Trastuzumab Biosimilar ALT02",
          "Trastuzumab Biosimilar EG12014",
          "Trastuzumab Biosimilar HLX02",
          "Trastuzumab Biosimilar PF-05280014",
          "Trastuzumab Biosimilar SB3",
          "Trastuzumab Biosimilar SIBP-01",
          "Trastuzumab-anns",
          "Trastuzumab-dkst",
          "Trastuzumab-dttb",
          "Trastuzumab-pkrb",
          "Trastuzumab-qyyp",
          "Trazimera"
        ]
      }
    ]
  },
  "civic.tid:343": {
    "id": "civic.tid:343",
    "label": "Dactolisib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C74072",
          "label": "Dactolisib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C74072"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "BEZ235",
      "Benzeneacetonitrile, 4-(2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo(4,5-c)quinolin-1-yl)-alpha,alpha-dimethyl-",
      "NVPBEZ235"
    ]
  },
  "civic.tid:55": {
    "id": "civic.tid:55",
    "label": "Ponatinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1364347",
          "label": "ponatinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:582",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3174"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:24309",
              "type": "Disease",
              "label": "Acute lymphoblastic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3167"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C95777"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AP-24534",
      "AP24534",
      "Benzamide, 3-(2-Imidazo(1,2-B)Pyridazin-3-Ylethynyl)-4-Methyl-N-(4-((4-Methyl-1- Piperazinyl)Methyl)-3-(Trifluoromethyl)Phenyl)"
    ]
  },
  "civic.tsgid:gVgGkpzxqiqLKaKyQVlfGYCzm6HVoRcE": {
    "id": "civic.tsgid:gVgGkpzxqiqLKaKyQVlfGYCzm6HVoRcE",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:173",
        "label": "Cytarabine",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:3041",
              "label": "cytarabine"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:575",
                  "type": "Disease",
                  "label": "CNS leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C5440"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:552",
                  "type": "Disease",
                  "label": "Acute myeloid leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3171"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C408"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          ".beta.-Cytosine Arabinoside",
          "1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone",
          "1-.beta.-D-Arabinofuranosylcytosine",
          "1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone",
          "1-Beta-D-arabinofuranosylcytosine",
          "1.beta.-D-Arabinofuranosylcytosine",
          "2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-",
          "2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-",
          "4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone",
          "ARA-cell",
          "Alexan",
          "Ara-C",
          "Arabine",
          "Arabinofuranosylcytosine",
          "Arabinosylcytosine",
          "Aracytidine",
          "Aracytin",
          "Aracytine",
          "Beta-Cytosine Arabinoside",
          "CHX-3311",
          "Cytarabinum",
          "Cytarbel",
          "Cytosar",
          "Cytosar-U",
          "Cytosine Arabinoside",
          "Cytosine-.beta.-arabinoside",
          "Cytosine-beta-arabinoside",
          "Erpalfa",
          "Starasid",
          "Tarabine PFS",
          "U 19920",
          "U-19920",
          "Udicil",
          "WR-28453"
        ]
      },
      {
        "id": "civic.tid:85",
        "label": "Gemcitabine",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:12574",
              "label": "gemcitabine"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:645",
                  "type": "Disease",
                  "label": "Ovarian cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7431"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:648",
                  "type": "Disease",
                  "label": "Pancreatic cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C43298"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C66876"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-(2-Oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose",
          "2'Deoxy-2',2'-Difluorocytidine",
          "DFdC",
          "DFdCyd",
          "Difluorodeoxycytidine"
        ]
      },
      {
        "id": "civic.tid:14194",
        "label": "Prednisolone",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:8638",
              "label": "prednisolone"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": []
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C769"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",
          ".delta.1-Hydrocortisone",
          "1,2-Dehydrohydrocortisone",
          "Adnisolone",
          "Aprednislon",
          "Capsoid",
          "Cortalone",
          "Cortisolone",
          "Dacortin H",
          "Decaprednil",
          "Decortin H",
          "Delta(1)Hydrocortisone",
          "Delta- Cortef",
          "Delta-Cortef",
          "Delta-Diona",
          "Delta-F",
          "Delta-Phoricol",
          "Delta1-dehydro-hydrocortisone",
          "Deltacortril",
          "Deltahydrocortisone",
          "Deltasolone",
          "Deltidrosol",
          "Dhasolone",
          "Di-Adreson-F",
          "Dontisolon D",
          "Estilsona",
          "Fisopred",
          "Frisolona",
          "Gupisone",
          "Hostacortin H",
          "Hydeltra",
          "Hydeltrasol",
          "Klismacort",
          "Kuhlprednon",
          "Lenisolone",
          "Lepi-Cortinolo",
          "Linola-H N",
          "Linola-H-Fett N",
          "Longiprednil",
          "Metacortandralone",
          "Meti Derm",
          "Meticortelone",
          "Opredsone",
          "Panafcortelone",
          "Precortisyl",
          "Pred-Clysma",
          "Predeltilone",
          "Predni-Coelin",
          "Predni-Helvacort",
          "Prednicortelone",
          "Prednisolonum",
          "Prelone",
          "Prenilone",
          "Sterane"
        ]
      },
      {
        "id": "civic.tid:68",
        "label": "Doxorubicin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:142433",
              "label": "doxorubicin hydrochloride"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:552",
                  "type": "Disease",
                  "label": "Acute myeloid leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3171"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:675",
                  "type": "Disease",
                  "label": "Thyroid cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7510"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:569",
                  "type": "Disease",
                  "label": "Bladder cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9334"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:601",
                  "type": "Disease",
                  "label": "Gastric cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9331"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:614",
                  "type": "Disease",
                  "label": "Hodgkin lymphoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9357"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:666",
                  "type": "Disease",
                  "label": "Small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4917"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:645",
                  "type": "Disease",
                  "label": "Ovarian cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7431"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:667",
                  "type": "Disease",
                  "label": "Soft tissue sarcoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9306"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C456"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroacetyl)-1-methoxy-5,12-naphthacenedione",
          "(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione",
          "14-Hydroxydaunomycin",
          "Adriablastin",
          "Hydroxydaunomycin",
          "Hydroxyl Daunorubicin",
          "Hydroxyldaunorubicin"
        ]
      }
    ]
  },
  "civic.tid:641": {
    "id": "civic.tid:641",
    "label": "Gilteritinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2105806",
          "label": "gilteritinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C116722"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide",
      "ASP-2215",
      "ASP2215",
      "Xospata"
    ]
  },
  "civic.tid:260": {
    "id": "civic.tid:260",
    "label": "Lestaurtinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C48402",
          "label": "Lestaurtinib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C48402"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-",
      "CEP-701",
      "KT-5555",
      "SPM-924"
    ]
  },
  "civic.tid:9": {
    "id": "civic.tid:9",
    "label": "Fedratinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2197490",
          "label": "fedratinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C88293"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Benzenesulfonamide, N-(1,1-dimethylethyl)-3-((5-methyl-2-((4-(2-(1-pyrrolidinyl)ethoxy)phenyl)amino)-4-pyrimidinyl)amino)-",
      "SAR302503",
      "TG101348"
    ]
  },
  "civic.tsgid:XAeVSqTvUR0yOysNE_Ihbb9r0EdZ4Z1z": {
    "id": "civic.tsgid:XAeVSqTvUR0yOysNE_Ihbb9r0EdZ4Z1z",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:5",
        "label": "Imatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282388",
              "label": "imatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:669",
                  "type": "Disease",
                  "label": "Systemic mastocytosis",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9235"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:634",
                  "type": "Disease",
                  "label": "Myelodysplastic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3247"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:33893",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia pediatric"
                },
                {
                  "id": "hemonc:667",
                  "type": "Disease",
                  "label": "Soft tissue sarcoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9306"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:616",
                  "type": "Disease",
                  "label": "Hypereosinophilic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27038"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62035"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide"
        ]
      },
      {
        "id": "civic.tid:13",
        "label": "Nilotinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:662281",
              "label": "nilotinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C48375"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide",
          "AMN 107 Base Form"
        ]
      },
      {
        "id": "civic.tid:6",
        "label": "Sorafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:495881",
              "label": "sorafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:65823",
                  "type": "Disease",
                  "label": "Thyroid cancer differentiated"
                },
                {
                  "id": "hemonc:612",
                  "type": "Disease",
                  "label": "Hepatocellular carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3099"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C61948"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BA4 43 9006",
          "BAY 43-9006",
          "Bay-439006"
        ]
      }
    ]
  },
  "civic.tid:17": {
    "id": "civic.tid:17",
    "label": "Alectinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1727455",
          "label": "alectinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C101790"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "5H-benzo(b)carbazole-3-carbonitrile, 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-",
      "AF-802",
      "AF802",
      "ALK Inhibitor RO5424802",
      "Alecensa",
      "CH5424802",
      "RG7853",
      "RO5424802"
    ]
  },
  "civic.tid:23": {
    "id": "civic.tid:23",
    "label": "Motesanib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C71896",
          "label": "Motesanib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C71896"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:24": {
    "id": "civic.tid:24",
    "label": "JAK2 Inhibitor AZD1480",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C91394",
          "label": "JAK2 Inhibitor AZD1480"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C91394"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "AZD-1480",
      "AZD1480"
    ]
  },
  "civic.tsgid:ngxhWeEUrfXP--l21wsFOlIfVCUCYTwb": {
    "id": "civic.tsgid:ngxhWeEUrfXP--l21wsFOlIfVCUCYTwb",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:19",
        "label": "Trametinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1425098",
              "label": "trametinib dimethyl sulfoxide"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C77908"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "GSK1120212",
          "JTP-74057",
          "MEK Inhibitor GSK1120212",
          "Mekinist",
          "N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide"
        ]
      },
      {
        "id": "civic.tid:29",
        "label": "Mirdametinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C52195",
              "label": "Mirdametinib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C52195"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "MEK Inhibitor PD0325901",
          "PD 901",
          "PD-0325901",
          "PD0325901"
        ]
      }
    ]
  },
  "civic.ctid:Txylx4lLlleKme7VZW1QkEDa_a2KuP3v": {
    "id": "civic.ctid:Txylx4lLlleKme7VZW1QkEDa_a2KuP3v",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:6",
        "label": "Sorafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:495881",
              "label": "sorafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:65823",
                  "type": "Disease",
                  "label": "Thyroid cancer differentiated"
                },
                {
                  "id": "hemonc:612",
                  "type": "Disease",
                  "label": "Hepatocellular carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3099"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C61948"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BA4 43 9006",
          "BAY 43-9006",
          "Bay-439006"
        ]
      },
      {
        "id": "civic.tid:28",
        "label": "Panitumumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:263034",
              "label": "panitumumab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1857"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABX-EGF",
          "ABX-EGF Monoclonal Antibody",
          "ABX-EGF, Clone E7.6.3",
          "E7.6.3",
          "Human IgG2K Monoclonal Antibody",
          "MoAb ABX-EGF",
          "MoAb E7.6.3",
          "Monoclonal Antibody ABX-EGF",
          "Monoclonal Antibody E7.6.3",
          "Vectibix"
        ]
      }
    ]
  },
  "civic.ctid:C9xIf4UNXDpcEhiDnKPFd6Gx6IIaT1E6": {
    "id": "civic.ctid:C9xIf4UNXDpcEhiDnKPFd6Gx6IIaT1E6",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:30",
        "label": "PLX4720",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "drugbank:DB06999",
              "label": "PLX-4720"
            }
          }
        ],
        "type": "TherapeuticAgent"
      },
      {
        "id": "civic.tid:477",
        "label": "Pictilisib Bismesylate",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C82380",
              "label": "Pictilisib Bismesylate"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C82380"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1- Ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine, Bimesylate Salt",
          "GDC-0941 Bismesylate",
          "GDC-0941 Dimesylate",
          "Pictilisib Dimesylate",
          "Thieno(3,2-d)pyrimidine, 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)-1-piperazinyl)methyl)-4-(4-morpholinyl)-, Methanesulfonate (1:2)"
        ]
      }
    ]
  },
  "civic.ctid:ga8GCopbz4xTHpmVbd_1oGREGpQbDTpo": {
    "id": "civic.ctid:ga8GCopbz4xTHpmVbd_1oGREGpQbDTpo",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:32",
        "label": "Capecitabine",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:194000",
              "label": "capecitabine"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:46096",
                  "type": "Disease",
                  "label": "Colorectal cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4978"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:585",
                  "type": "Disease",
                  "label": "Colon cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9242"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1794"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine",
          "Ro 09-1978/000",
          "Xeloda"
        ]
      },
      {
        "id": "civic.tid:4",
        "label": "Vemurafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1147220",
              "label": "vemurafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:594",
                  "type": "Disease",
                  "label": "Erdheim-Chester disease",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C53972"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C64768"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
          "BRAF (V600E) Kinase Inhibitor RO5185426",
          "BRAF(V600E) Kinase Inhibitor RO5185426",
          "PLX-4032",
          "PLX4032",
          "RG 7204",
          "RG7204",
          "RO 5185426",
          "Zelboraf"
        ]
      },
      {
        "id": "civic.tid:33",
        "label": "Bevacizumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2046138",
              "label": "bevacizumab-awwb"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002289",
                  "type": "Disease",
                  "label": "Carcinoma, Non-Small-Cell Lung",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D003110",
                  "type": "Disease",
                  "label": "Colonic Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2953"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002583",
                  "type": "Disease",
                  "label": "Uterine Cervical Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9311"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002292",
                  "type": "Disease",
                  "label": "Carcinoma, Renal Cell",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D005909",
                  "type": "Disease",
                  "label": "Glioblastoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3058"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C2039"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABP 215",
          "Anti-VEGF",
          "Anti-VEGF Humanized Monoclonal Antibody",
          "Anti-VEGF RhuMAb",
          "Avastin",
          "BP102",
          "BP102 Biosimilar",
          "Bevacizumab Awwb",
          "Bevacizumab Biosimilar ABP 215",
          "Bevacizumab Biosimilar BEVZ92",
          "Bevacizumab Biosimilar BI 695502",
          "Bevacizumab Biosimilar CBT 124",
          "Bevacizumab Biosimilar CT-P16",
          "Bevacizumab Biosimilar FKB238",
          "Bevacizumab Biosimilar GB-222",
          "Bevacizumab Biosimilar HD204",
          "Bevacizumab Biosimilar HLX04",
          "Bevacizumab Biosimilar IBI305",
          "Bevacizumab Biosimilar LY01008",
          "Bevacizumab Biosimilar MIL60",
          "Bevacizumab Biosimilar MYL-1402O",
          "Bevacizumab Biosimilar Mvasi",
          "Bevacizumab Biosimilar QL 1101",
          "Bevacizumab Biosimilar RPH-001",
          "Bevacizumab Biosimilar SCT501",
          "Bevacizumab Biosimilar Zirabev",
          "Bevacizumab-awwb",
          "Bevacizumab-bvzr",
          "HD204",
          "Immunoglobulin G1 (Human-Mouse Monoclonal RhuMab-VEGF Gamma-Chain Anti-Human Vascular Endothelial Growth Factor), Disulfide With Human-Mouse Monoclonal RhuMab-VEGF Light Chain, Dimer",
          "MYL-1402O",
          "Mvasi",
          "Recombinant Humanized Anti-VEGF Monoclonal Antibody",
          "RhuMab-VEGF",
          "SCT501",
          "Zirabev"
        ]
      }
    ]
  },
  "civic.tid:46": {
    "id": "civic.tid:46",
    "label": "Hormone Therapy",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C147908",
          "label": "Hormone Therapy Agent"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C15445"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Chemotherapy-Hormones/Steroids",
      "Endocrine Therapy",
      "Hormonal Therapy",
      "Hormone Treatment",
      "Hormones"
    ]
  },
  "civic.tsgid:n4NuIj-lZJTjzG0Zb7E2v0XU0V35wlV6": {
    "id": "civic.tsgid:n4NuIj-lZJTjzG0Zb7E2v0XU0V35wlV6",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:20",
        "label": "Dasatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1546019",
              "label": "dasatinib anhydrous"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C38713"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-, Monohydrate",
          "BMS-354825",
          "Dasatinib Hydrate",
          "Dasatinib Monohydrate",
          "Sprycel"
        ]
      },
      {
        "id": "civic.tid:5",
        "label": "Imatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282388",
              "label": "imatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:669",
                  "type": "Disease",
                  "label": "Systemic mastocytosis",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9235"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:634",
                  "type": "Disease",
                  "label": "Myelodysplastic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3247"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:33893",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia pediatric"
                },
                {
                  "id": "hemonc:667",
                  "type": "Disease",
                  "label": "Soft tissue sarcoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9306"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:616",
                  "type": "Disease",
                  "label": "Hypereosinophilic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27038"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62035"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide"
        ]
      },
      {
        "id": "civic.tid:13",
        "label": "Nilotinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:662281",
              "label": "nilotinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C48375"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide",
          "AMN 107 Base Form"
        ]
      }
    ]
  },
  "civic.tid:68": {
    "id": "civic.tid:68",
    "label": "Doxorubicin",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:142433",
          "label": "doxorubicin hydrochloride"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:552",
              "type": "Disease",
              "label": "Acute myeloid leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3171"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:675",
              "type": "Disease",
              "label": "Thyroid cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7510"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:569",
              "type": "Disease",
              "label": "Bladder cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9334"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:601",
              "type": "Disease",
              "label": "Gastric cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9331"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:614",
              "type": "Disease",
              "label": "Hodgkin lymphoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9357"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:666",
              "type": "Disease",
              "label": "Small cell lung cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C4917"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:645",
              "type": "Disease",
              "label": "Ovarian cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C7431"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:667",
              "type": "Disease",
              "label": "Soft tissue sarcoma",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9306"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C456"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroacetyl)-1-methoxy-5,12-naphthacenedione",
      "(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione",
      "14-Hydroxydaunomycin",
      "Adriablastin",
      "Hydroxydaunomycin",
      "Hydroxyl Daunorubicin",
      "Hydroxyldaunorubicin"
    ]
  },
  "civic.tsgid:_4VF-9RhQ30VRa2AZYtxUNJ4lboZYB1X": {
    "id": "civic.tsgid:_4VF-9RhQ30VRa2AZYtxUNJ4lboZYB1X",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:43",
        "label": "Akt Inhibitor MK2206",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C90581",
              "label": "Akt Inhibitor MK2206"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C90581"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1,2,4-Triazolo(3,4-f)(1,6)naphthyridin-3(2H)-one, 8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl-",
          "MK 2206",
          "MK-2206",
          "MK-2206 FREE BASE",
          "MK2206"
        ]
      },
      {
        "id": "civic.tid:141",
        "label": "Pictilisib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C165479",
              "label": "Pictilisib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C165479"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "2-(1H-indazol-4-yl)-6-((4-(methanesulfonyl)piperazin-1-yl)methyl)-4-(morpholin-4-yl)thieno(3,2-d)pyrimidine",
          "4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno(3,2-d)pyrimidin-4-yl)morpholine",
          "GDC 0941",
          "GDC-0941",
          "GDC0941"
        ]
      }
    ]
  },
  "civic.tsgid:MJtdjSZMt7R1cOWlhK2Kv7xnNUzVRmRQ": {
    "id": "civic.tsgid:MJtdjSZMt7R1cOWlhK2Kv7xnNUzVRmRQ",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:115",
        "label": "PI3K/BET Inhibitor LY294002",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C148229",
              "label": "PI3K/BET Inhibitor LY294002"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C148229"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one",
          "2-Morpholin-4-yl-8-phenylchromen-4-one",
          "4H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl-",
          "LY 294002",
          "LY-294002",
          "LY294002"
        ]
      },
      {
        "id": "civic.tid:112",
        "label": "Capivasertib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C102564",
              "label": "Capivasertib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C102564"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AZD5363"
        ]
      }
    ]
  },
  "civic.ctid:MJtdjSZMt7R1cOWlhK2Kv7xnNUzVRmRQ": {
    "id": "civic.ctid:MJtdjSZMt7R1cOWlhK2Kv7xnNUzVRmRQ",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:112",
        "label": "Capivasertib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C102564",
              "label": "Capivasertib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C102564"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AZD5363"
        ]
      },
      {
        "id": "civic.tid:115",
        "label": "PI3K/BET Inhibitor LY294002",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C148229",
              "label": "PI3K/BET Inhibitor LY294002"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C148229"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one",
          "2-Morpholin-4-yl-8-phenylchromen-4-one",
          "4H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl-",
          "LY 294002",
          "LY-294002",
          "LY294002"
        ]
      }
    ]
  },
  "civic.ctid:SlRfPtAlZWrxQuj9zLGMRKRtxOV0-KKL": {
    "id": "civic.ctid:SlRfPtAlZWrxQuj9zLGMRKRtxOV0-KKL",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:41",
        "label": "Everolimus",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:141704",
              "label": "everolimus"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:641",
                  "type": "Disease",
                  "label": "Neuroendocrine tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3809"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:647",
                  "type": "Disease",
                  "label": "Pancreatic NET",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27720"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:45070",
                  "type": "Disease",
                  "label": "Subependymal giant cell astrocytoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3696"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C48387"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone",
          "42-O-(2-Hydroxy)ethyl Rapamycin",
          "Afinitor",
          "Certican",
          "RAD 001",
          "RAD001",
          "Votubia",
          "Zortress"
        ]
      },
      {
        "id": "civic.tid:485",
        "label": "Binimetinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2049122",
              "label": "binimetinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C84865"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ARRY-162",
          "ARRY-438162",
          "MEK162",
          "Mektovi"
        ]
      }
    ]
  },
  "civic.tid:274": {
    "id": "civic.tid:274",
    "label": "Patidegib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C80063",
          "label": "Patidegib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C80063"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "FIN-5",
      "IP9 Free Base",
      "IPI-926",
      "IPI-926 Free Base",
      "Saridegib",
      "Smoothened Antagonist IPI-926"
    ]
  },
  "civic.tsgid:wsLrVLsW3tlJpvelphvNfi7j0WAQrFVD": {
    "id": "civic.tsgid:wsLrVLsW3tlJpvelphvNfi7j0WAQrFVD",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:157",
        "label": "Sunitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:357977",
              "label": "sunitinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:647",
                  "type": "Disease",
                  "label": "Pancreatic NET",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27720"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C71622"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-"
        ]
      },
      {
        "id": "civic.tid:6",
        "label": "Sorafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:495881",
              "label": "sorafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:65823",
                  "type": "Disease",
                  "label": "Thyroid cancer differentiated"
                },
                {
                  "id": "hemonc:612",
                  "type": "Disease",
                  "label": "Hepatocellular carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3099"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C61948"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BA4 43 9006",
          "BAY 43-9006",
          "Bay-439006"
        ]
      }
    ]
  },
  "civic.tid:342": {
    "id": "civic.tid:342",
    "label": "Cobimetinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1722365",
          "label": "cobimetinib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "ChEMBL",
          "has_indications": [
            {
              "id": "mesh:D009369",
              "type": "Disease",
              "label": "Neoplasms",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3262"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C68923"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "Cotellic",
      "GDC-0973",
      "MEK Inhibitor GDC-0973",
      "XL518"
    ]
  },
  "civic.tid:36": {
    "id": "civic.tid:36",
    "label": "PD173074",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "iuphar.ligand:5037",
          "label": "PD173074"
        }
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tid:319": {
    "id": "civic.tid:319",
    "label": "AZD3463",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "iuphar.ligand:7706",
          "label": "AZD3463"
        }
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.ctid:wV3Rrz2FQm2499F4G_2mMEekgKValyx3": {
    "id": "civic.ctid:wV3Rrz2FQm2499F4G_2mMEekgKValyx3",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:4",
        "label": "Vemurafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1147220",
              "label": "vemurafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:594",
                  "type": "Disease",
                  "label": "Erdheim-Chester disease",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C53972"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C64768"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
          "BRAF (V600E) Kinase Inhibitor RO5185426",
          "BRAF(V600E) Kinase Inhibitor RO5185426",
          "PLX-4032",
          "PLX4032",
          "RG 7204",
          "RG7204",
          "RO 5185426",
          "Zelboraf"
        ]
      },
      {
        "id": "civic.tid:14",
        "label": "Gefitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:328134",
              "label": "gefitinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1855"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline",
          "Iressa",
          "N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholin) Propoxy]-4-quinazolinamine",
          "ZD 1839",
          "ZD1839"
        ]
      },
      {
        "id": "civic.tid:16",
        "label": "Cetuximab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:318341",
              "label": "cetuximab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D006258",
                  "type": "Disease",
                  "label": "Head and Neck Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4013"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002294",
                  "type": "Disease",
                  "label": "Carcinoma, Squamous Cell",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2929"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1723"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Cetuximab Biosimilar CDP-1",
          "Cetuximab Biosimilar CMAB009",
          "Cetuximab Biosimilar KL 140",
          "Chimeric Anti-EGFR Monoclonal Antibody",
          "Chimeric MoAb C225",
          "Chimeric Monoclonal Antibody C225",
          "Erbitux",
          "IMC-C225"
        ]
      }
    ]
  },
  "civic.ctid:wSyKTzr1BRXrney-dvXpG5oeafYxe5rS": {
    "id": "civic.ctid:wSyKTzr1BRXrney-dvXpG5oeafYxe5rS",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:343",
        "label": "Dactolisib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C74072",
              "label": "Dactolisib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C74072"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BEZ235",
          "Benzeneacetonitrile, 4-(2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo(4,5-c)quinolin-1-yl)-alpha,alpha-dimethyl-",
          "NVPBEZ235"
        ]
      },
      {
        "id": "civic.tid:344",
        "label": "GDC-0879",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "iuphar.ligand:5681",
              "label": "GDC-0879"
            }
          }
        ],
        "type": "TherapeuticAgent"
      }
    ]
  },
  "civic.tsgid:tWJleGyed3g0Eqv1ASxYxVix6lJUtxhw": {
    "id": "civic.tsgid:tWJleGyed3g0Eqv1ASxYxVix6lJUtxhw",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:4",
        "label": "Vemurafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1147220",
              "label": "vemurafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:594",
                  "type": "Disease",
                  "label": "Erdheim-Chester disease",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C53972"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C64768"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
          "BRAF (V600E) Kinase Inhibitor RO5185426",
          "BRAF(V600E) Kinase Inhibitor RO5185426",
          "PLX-4032",
          "PLX4032",
          "RG 7204",
          "RG7204",
          "RO 5185426",
          "Zelboraf"
        ]
      },
      {
        "id": "civic.tid:19",
        "label": "Trametinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1425098",
              "label": "trametinib dimethyl sulfoxide"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C77908"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "GSK1120212",
          "JTP-74057",
          "MEK Inhibitor GSK1120212",
          "Mekinist",
          "N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide"
        ]
      }
    ]
  },
  "civic.ctid:3yTLBT7LVjztI3zPC4FWN2nJQIyFTsx2": {
    "id": "civic.ctid:3yTLBT7LVjztI3zPC4FWN2nJQIyFTsx2",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:112",
        "label": "Capivasertib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C102564",
              "label": "Capivasertib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C102564"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AZD5363"
        ]
      },
      {
        "id": "civic.tid:84",
        "label": "Trastuzumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2103478",
              "label": "trastuzumab-dkst"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D001943",
                  "type": "Disease",
                  "label": "Breast Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2910"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1647"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABP 980",
          "ALT02",
          "Anti-ERB-2",
          "Anti-HER2/c-erbB2 Monoclonal Antibody",
          "Anti-c-ERB-2",
          "Anti-c-erbB2 Monoclonal Antibody",
          "Anti-erbB-2",
          "Anti-erbB2 Monoclonal Antibody",
          "Anti-p185-HER2",
          "C-erb-2 Monoclonal Antibody",
          "HER2 Monoclonal Antibody",
          "Herceptin",
          "Herceptin Biosimilar PF-05280014",
          "Herceptin Trastuzumab Biosimilar PF-05280014",
          "Herzuma",
          "Immunoglobulin G 1 (Human-Mouse Monoclonal RhuMab HER2gamma1-Chain Antihuman P185(Sup C-erbB2) Receptor), Disulfide With Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer",
          "Kanjinti",
          "MoAb HER2",
          "Monoclonal Antibody C-erb-2",
          "Monoclonal Antibody HER2",
          "Ogivri",
          "Ontruzant",
          "PF-05280014",
          "RO0452317",
          "RhuMAb HER2",
          "SB3",
          "Trastuzumab Biosimilar ABP 980",
          "Trastuzumab Biosimilar ALT02",
          "Trastuzumab Biosimilar EG12014",
          "Trastuzumab Biosimilar HLX02",
          "Trastuzumab Biosimilar PF-05280014",
          "Trastuzumab Biosimilar SB3",
          "Trastuzumab Biosimilar SIBP-01",
          "Trastuzumab-anns",
          "Trastuzumab-dkst",
          "Trastuzumab-dttb",
          "Trastuzumab-pkrb",
          "Trastuzumab-qyyp",
          "Trazimera"
        ]
      }
    ]
  },
  "civic.ctid:rCQ3ME-7NyYYWvp6hnY7uiZVkQckf9-K": {
    "id": "civic.ctid:rCQ3ME-7NyYYWvp6hnY7uiZVkQckf9-K",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:112",
        "label": "Capivasertib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C102564",
              "label": "Capivasertib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C102564"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AZD5363"
        ]
      },
      {
        "id": "civic.tid:45",
        "label": "Lapatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:480167",
              "label": "lapatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C26653"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "GSK572016",
          "GW 2016",
          "GW2016",
          "GW572016"
        ]
      }
    ]
  },
  "civic.tid:30": {
    "id": "civic.tid:30",
    "label": "PLX4720",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "drugbank:DB06999",
          "label": "PLX-4720"
        }
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tsgid:6f8Y3lvR4NV9ytfANIpnRCICPpmWkjSR": {
    "id": "civic.tsgid:6f8Y3lvR4NV9ytfANIpnRCICPpmWkjSR",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:376",
        "label": "RapaLink-1",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "iuphar.ligand:9212",
              "label": "RapaLink-1"
            }
          }
        ],
        "type": "TherapeuticAgent"
      },
      {
        "id": "civic.tid:469",
        "label": "Sirolimus",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:35302",
              "label": "sirolimus"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:37829",
                  "type": "Disease",
                  "label": "PEComa",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C38150"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1212"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,2",
          "AY 22989",
          "RAPA",
          "RAPAMYCIN",
          "Rapamune",
          "SILA 9268A",
          "WY-090217"
        ]
      }
    ]
  },
  "civic.tsgid:D46xUyn1b10HAjpKd6R9Pk2F5e_Dhj3C": {
    "id": "civic.tsgid:D46xUyn1b10HAjpKd6R9Pk2F5e_Dhj3C",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:389",
        "label": "Perifosine",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C1727",
              "label": "Perifosine"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1727"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-[[Hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethylpiperidinium, Inner Salt",
          "D21266",
          "Octadecyl-(N,N-dimethylpiperidino-4-yl)phosphate",
          "Octadecylphosphopiperidine"
        ]
      },
      {
        "id": "civic.tid:83",
        "label": "Temsirolimus",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:657797",
              "label": "temsirolimus"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002292",
                  "type": "Disease",
                  "label": "Carcinoma, Renal Cell",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1844"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "42-(3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin",
          "CCI-779",
          "CCI-779 Rapamycin Analog",
          "Cell Cycle Inhibitor 779",
          "Rapamycin Analog",
          "Rapamycin Analog CCI-779",
          "Torisel"
        ]
      }
    ]
  },
  "civic.tsgid:b5WTtG7LRkGXmkK9gDSA00gJ_AiZvgnj": {
    "id": "civic.tsgid:b5WTtG7LRkGXmkK9gDSA00gJ_AiZvgnj",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:21",
        "label": "Crenolanib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C64639",
              "label": "Crenolanib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C64639"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-Piperidinamine, 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1Hbenzimidazol-1-yl]-8-quinolinyl]-",
          "CP-868,596",
          "CP-868596",
          "PDGFR Inhibitor CP-868596",
          "[1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine"
        ]
      },
      {
        "id": "civic.tid:5",
        "label": "Imatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282388",
              "label": "imatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:669",
                  "type": "Disease",
                  "label": "Systemic mastocytosis",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9235"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:634",
                  "type": "Disease",
                  "label": "Myelodysplastic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3247"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:33893",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia pediatric"
                },
                {
                  "id": "hemonc:667",
                  "type": "Disease",
                  "label": "Soft tissue sarcoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9306"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:616",
                  "type": "Disease",
                  "label": "Hypereosinophilic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27038"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62035"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide"
        ]
      }
    ]
  },
  "civic.tid:457": {
    "id": "civic.tid:457",
    "label": "Trastuzumab Emtansine",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1371041",
          "label": "ado-trastuzumab emtansine"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C82492"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "ADO-TRASTUZUMAB EMTANSINE",
      "Ado Trastuzumab Emtansine",
      "Immunoglobulin G1, Anti-(Human P185neu Receptor) (Human-Mouse Monoclonal RhuMab HER2 Gamma1-Chain), Disulfide With Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer, Tetraamide With N2'-(3-((1-((4-carboxycyclohexyl)methyl)-2,5-dioxo-3-pyrrolidinyl)thio)-1-oxopropyl)-N2'-deacetylMaytansine",
      "Kadcyla",
      "PRO132365",
      "RO5304020",
      "T-DM1",
      "Trastuzumab-DM1",
      "Trastuzumab-MCC-DM1",
      "Trastuzumab-MCC-DM1 Antibody-Drug Conjugate",
      "Trastuzumab-MCC-DM1 Immunoconjugate"
    ]
  },
  "civic.tid:465": {
    "id": "civic.tid:465",
    "label": "Canertinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C77588",
          "label": "Canertinib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C77588"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-",
      "N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide"
    ]
  },
  "civic.ctid:lKzFO2wvX0aR43_nXTZ19I1vjsXGQ6R8": {
    "id": "civic.ctid:lKzFO2wvX0aR43_nXTZ19I1vjsXGQ6R8",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:141",
        "label": "Pictilisib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C165479",
              "label": "Pictilisib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C165479"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "2-(1H-indazol-4-yl)-6-((4-(methanesulfonyl)piperazin-1-yl)methyl)-4-(morpholin-4-yl)thieno(3,2-d)pyrimidine",
          "4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno(3,2-d)pyrimidin-4-yl)morpholine",
          "GDC 0941",
          "GDC-0941",
          "GDC0941"
        ]
      },
      {
        "id": "civic.tid:326",
        "label": "Cisplatin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2555",
              "label": "cisplatin"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:671",
                  "type": "Disease",
                  "label": "Testicular cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C5053"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:645",
                  "type": "Disease",
                  "label": "Ovarian cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7431"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:569",
                  "type": "Disease",
                  "label": "Bladder cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9334"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C376"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(SP-4-2)-Diamminedichloroplatinum",
          "Abiplatin",
          "Blastolem",
          "Briplatin",
          "CDDP",
          "Cis-diammine-dichloroplatinum",
          "Cis-diamminedichloridoplatinum",
          "Cis-diamminedichloro Platinum (II)",
          "Cis-diamminedichloroplatinum",
          "Cis-dichloroammine Platinum (II)",
          "Cis-platinous Diamine Dichloride",
          "Cis-platinum",
          "Cis-platinum II",
          "Cis-platinum II Diamine Dichloride",
          "Cismaplat",
          "Cisplatina",
          "Cisplatinum",
          "Cisplatyl",
          "Citoplatino",
          "Citosin",
          "Cysplatyna",
          "DDP",
          "Lederplatin",
          "Metaplatin",
          "Neoplatin",
          "Peyrone's Chloride",
          "Peyrone's Salt",
          "Placis",
          "Plastistil",
          "Platamine",
          "Platiblastin",
          "Platiblastin-S",
          "Platinex",
          "Platinol",
          "Platinol- AQ",
          "Platinol-AQ",
          "Platinol-AQ VHA Plus",
          "Platinoxan",
          "Platinum",
          "Platinum Diamminodichloride",
          "Platinum, Diaminedichloro-, Cis- (8CI)",
          "Platiran",
          "Platistin",
          "Platosin"
        ]
      }
    ]
  },
  "civic.tid:503": {
    "id": "civic.tid:503",
    "label": "Tandutinib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C48404",
          "label": "Tandutinib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C48404"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "1-Piperazinecarboxamide, 4-(6-Methoxy-7-(3-(1-piperidinyl)propoxy)-4-quinazolinyl)-N-(4-(1-methylethoxy)phenyl)-",
      "CT53518",
      "MLN 518",
      "MLN518"
    ]
  },
  "civic.tsgid:KuD9fVxtGEzkO9TjmpGN0Xt5x68Qm7S-": {
    "id": "civic.tsgid:KuD9fVxtGEzkO9TjmpGN0Xt5x68Qm7S-",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:15",
        "label": "Erlotinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:337525",
              "label": "erlotinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:648",
                  "type": "Disease",
                  "label": "Pancreatic cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C43298"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C65530"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent"
      },
      {
        "id": "civic.tid:14",
        "label": "Gefitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:328134",
              "label": "gefitinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1855"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline",
          "Iressa",
          "N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholin) Propoxy]-4-quinazolinamine",
          "ZD 1839",
          "ZD1839"
        ]
      },
      {
        "id": "civic.tid:90",
        "label": "Multikinase Inhibitor AEE788",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C48369",
              "label": "Multikinase Inhibitor AEE788"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C48369"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AEE 788",
          "AEE-788",
          "AEE788"
        ]
      }
    ]
  },
  "civic.tsgid:Bp7LSZxv3sM5AUjPNf7nTRGI6VHQfjmY": {
    "id": "civic.tsgid:Bp7LSZxv3sM5AUjPNf7nTRGI6VHQfjmY",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:5",
        "label": "Imatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282388",
              "label": "imatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:669",
                  "type": "Disease",
                  "label": "Systemic mastocytosis",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9235"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:634",
                  "type": "Disease",
                  "label": "Myelodysplastic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3247"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:33893",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia pediatric"
                },
                {
                  "id": "hemonc:667",
                  "type": "Disease",
                  "label": "Soft tissue sarcoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9306"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:616",
                  "type": "Disease",
                  "label": "Hypereosinophilic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27038"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62035"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide"
        ]
      },
      {
        "id": "civic.tid:55",
        "label": "Ponatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1364347",
              "label": "ponatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C95777"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AP-24534",
          "AP24534",
          "Benzamide, 3-(2-Imidazo(1,2-B)Pyridazin-3-Ylethynyl)-4-Methyl-N-(4-((4-Methyl-1- Piperazinyl)Methyl)-3-(Trifluoromethyl)Phenyl)"
        ]
      }
    ]
  },
  "civic.tsgid:EFgr37MY89Im6stpaZjt2xyMOX1et0He": {
    "id": "civic.tsgid:EFgr37MY89Im6stpaZjt2xyMOX1et0He",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:27",
        "label": "Regorafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1312397",
              "label": "regorafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C78204"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide",
          "BAY 73-4506",
          "REGORAFENIB ANHYDROUS",
          "Stivarga"
        ]
      },
      {
        "id": "civic.tid:5",
        "label": "Imatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282388",
              "label": "imatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:669",
                  "type": "Disease",
                  "label": "Systemic mastocytosis",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9235"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:634",
                  "type": "Disease",
                  "label": "Myelodysplastic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3247"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:33893",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia pediatric"
                },
                {
                  "id": "hemonc:667",
                  "type": "Disease",
                  "label": "Soft tissue sarcoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9306"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:616",
                  "type": "Disease",
                  "label": "Hypereosinophilic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27038"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62035"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide"
        ]
      },
      {
        "id": "civic.tid:55",
        "label": "Ponatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1364347",
              "label": "ponatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C95777"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AP-24534",
          "AP24534",
          "Benzamide, 3-(2-Imidazo(1,2-B)Pyridazin-3-Ylethynyl)-4-Methyl-N-(4-((4-Methyl-1- Piperazinyl)Methyl)-3-(Trifluoromethyl)Phenyl)"
        ]
      },
      {
        "id": "civic.tid:157",
        "label": "Sunitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:357977",
              "label": "sunitinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:647",
                  "type": "Disease",
                  "label": "Pancreatic NET",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27720"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C71622"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-"
        ]
      }
    ]
  },
  "civic.tsgid:Jv_L58rkjyTyxmdr8-aXf8RjFkPe9Pnn": {
    "id": "civic.tsgid:Jv_L58rkjyTyxmdr8-aXf8RjFkPe9Pnn",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:157",
        "label": "Sunitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:357977",
              "label": "sunitinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:647",
                  "type": "Disease",
                  "label": "Pancreatic NET",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27720"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C71622"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-"
        ]
      },
      {
        "id": "civic.tid:5",
        "label": "Imatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282388",
              "label": "imatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:669",
                  "type": "Disease",
                  "label": "Systemic mastocytosis",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9235"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:634",
                  "type": "Disease",
                  "label": "Myelodysplastic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3247"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:33893",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia pediatric"
                },
                {
                  "id": "hemonc:667",
                  "type": "Disease",
                  "label": "Soft tissue sarcoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9306"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:616",
                  "type": "Disease",
                  "label": "Hypereosinophilic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27038"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62035"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide"
        ]
      },
      {
        "id": "civic.tid:27",
        "label": "Regorafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1312397",
              "label": "regorafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C78204"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide",
          "BAY 73-4506",
          "REGORAFENIB ANHYDROUS",
          "Stivarga"
        ]
      }
    ]
  },
  "civic.tsgid:pRXLOTUcGy266tKwrptqo3E3XUUSTYZh": {
    "id": "civic.tsgid:pRXLOTUcGy266tKwrptqo3E3XUUSTYZh",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:27",
        "label": "Regorafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1312397",
              "label": "regorafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C78204"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide",
          "BAY 73-4506",
          "REGORAFENIB ANHYDROUS",
          "Stivarga"
        ]
      },
      {
        "id": "civic.tid:5",
        "label": "Imatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282388",
              "label": "imatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:669",
                  "type": "Disease",
                  "label": "Systemic mastocytosis",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9235"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:634",
                  "type": "Disease",
                  "label": "Myelodysplastic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3247"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:33893",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia pediatric"
                },
                {
                  "id": "hemonc:667",
                  "type": "Disease",
                  "label": "Soft tissue sarcoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9306"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:616",
                  "type": "Disease",
                  "label": "Hypereosinophilic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27038"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62035"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide"
        ]
      },
      {
        "id": "civic.tid:55",
        "label": "Ponatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1364347",
              "label": "ponatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C95777"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AP-24534",
          "AP24534",
          "Benzamide, 3-(2-Imidazo(1,2-B)Pyridazin-3-Ylethynyl)-4-Methyl-N-(4-((4-Methyl-1- Piperazinyl)Methyl)-3-(Trifluoromethyl)Phenyl)"
        ]
      }
    ]
  },
  "civic.tsgid:dGeFezSlKdWXf9xk5Kn9yUW_wRthhsRt": {
    "id": "civic.tsgid:dGeFezSlKdWXf9xk5Kn9yUW_wRthhsRt",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:20",
        "label": "Dasatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1546019",
              "label": "dasatinib anhydrous"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C38713"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-, Monohydrate",
          "BMS-354825",
          "Dasatinib Hydrate",
          "Dasatinib Monohydrate",
          "Sprycel"
        ]
      },
      {
        "id": "civic.tid:537",
        "label": "Imatinib Mesylate",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:282388",
              "label": "imatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:669",
                  "type": "Disease",
                  "label": "Systemic mastocytosis",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9235"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:634",
                  "type": "Disease",
                  "label": "Myelodysplastic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3247"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:33893",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia pediatric"
                },
                {
                  "id": "hemonc:667",
                  "type": "Disease",
                  "label": "Soft tissue sarcoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9306"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:616",
                  "type": "Disease",
                  "label": "Hypereosinophilic syndrome",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27038"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1687"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide Monomethanesulfonate",
          "CGP 57148",
          "CGP57148B",
          "Gleevec",
          "Glivec",
          "STI 571",
          "STI-571",
          "STI571"
        ]
      }
    ]
  },
  "civic.tsgid:mnS64Wd7Idu3tHEYX3g8MGHOl43L8wuU": {
    "id": "civic.tsgid:mnS64Wd7Idu3tHEYX3g8MGHOl43L8wuU",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:14",
        "label": "Gefitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:328134",
              "label": "gefitinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1855"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline",
          "Iressa",
          "N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholin) Propoxy]-4-quinazolinamine",
          "ZD 1839",
          "ZD1839"
        ]
      },
      {
        "id": "civic.tid:146",
        "label": "Afatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1430438",
              "label": "afatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:25316",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer squamous"
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C66940"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(2e)-N-(4-(3-Chloro-4-Fluoroanilino)-7-(((3s)-Oxolan-3-yl)Oxy)Quinoxazolin-6-yl)-4-(Dimethylamino)But-2-Enamide",
          "BIBW 2992",
          "BIBW2992"
        ]
      }
    ]
  },
  "civic.tid:568": {
    "id": "civic.tid:568",
    "label": "U0126",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "iuphar.ligand:5282",
          "label": "U0126"
        }
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tsgid:R22Zf5CPlJKGeo-aqhjXFczWKERAMSbp": {
    "id": "civic.tsgid:R22Zf5CPlJKGeo-aqhjXFczWKERAMSbp",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:68",
        "label": "Doxorubicin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:142433",
              "label": "doxorubicin hydrochloride"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:552",
                  "type": "Disease",
                  "label": "Acute myeloid leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3171"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:675",
                  "type": "Disease",
                  "label": "Thyroid cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7510"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:569",
                  "type": "Disease",
                  "label": "Bladder cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9334"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:601",
                  "type": "Disease",
                  "label": "Gastric cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9331"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:614",
                  "type": "Disease",
                  "label": "Hodgkin lymphoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9357"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:666",
                  "type": "Disease",
                  "label": "Small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4917"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:645",
                  "type": "Disease",
                  "label": "Ovarian cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7431"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:667",
                  "type": "Disease",
                  "label": "Soft tissue sarcoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9306"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C456"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroacetyl)-1-methoxy-5,12-naphthacenedione",
          "(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione",
          "14-Hydroxydaunomycin",
          "Adriablastin",
          "Hydroxydaunomycin",
          "Hydroxyl Daunorubicin",
          "Hydroxyldaunorubicin"
        ]
      },
      {
        "id": "civic.tid:422",
        "label": "Methotrexate",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:6851",
              "label": "methotrexate"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": []
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C642"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-Amino-10-methylfolic Acid",
          "4-Amino-4-deoxy-10-methylpteroyl-L-glutamic Acid",
          "Abitrexate",
          "Alpha-Methopterin",
          "Amethopterin",
          "Brimexate",
          "CL 14377",
          "CL-14377",
          "Emtexate",
          "Emthexat",
          "Emthexate",
          "Farmitrexat",
          "Fauldexato",
          "Folex",
          "Folex PFS",
          "Lantarel",
          "Ledertrexate",
          "Lumexon",
          "MTX",
          "Maxtrex",
          "Medsatrexate",
          "Metex",
          "Methoblastin",
          "Methotrexate LPF",
          "Methotrexate Methylaminopterin",
          "Methotrexatum",
          "Metotrexato",
          "Metrotex",
          "Mexate",
          "Mexate-AQ",
          "N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic Acid",
          "Novatrex",
          "Rheumatrex",
          "Texate",
          "Tremetex",
          "Trexeron",
          "Trixilem",
          "WR-19039"
        ]
      }
    ]
  },
  "civic.ctid:vz_W7U3qrxseu_SVPiT9P9WorfLg9cvg": {
    "id": "civic.ctid:vz_W7U3qrxseu_SVPiT9P9WorfLg9cvg",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:28",
        "label": "Panitumumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:263034",
              "label": "panitumumab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1857"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABX-EGF",
          "ABX-EGF Monoclonal Antibody",
          "ABX-EGF, Clone E7.6.3",
          "E7.6.3",
          "Human IgG2K Monoclonal Antibody",
          "MoAb ABX-EGF",
          "MoAb E7.6.3",
          "Monoclonal Antibody ABX-EGF",
          "Monoclonal Antibody E7.6.3",
          "Vectibix"
        ]
      },
      {
        "id": "civic.tid:101",
        "label": "Irinotecan",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:153329",
              "label": "irinotecan hydrochloride"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:46096",
                  "type": "Disease",
                  "label": "Colorectal cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4978"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62040"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(+)-(4S)-4,11-diethyl-4-hydroxy-9-[(4-piperidino-piperidino)carbonyloxy]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinol-3,14,(4H,12H)-dione",
          "(+)-7-ethyl-10-hydroxycamptothecine 10-[1,4'-bipiperidine]-1'-carboxylate",
          "7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin",
          "[1,4'-bipiperidine]-1'-carboxylic Acid (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl Ester"
        ]
      }
    ]
  },
  "civic.ctid:gfytNdjDYwoQXo5CF4jOdAg4wrcu2AFh": {
    "id": "civic.ctid:gfytNdjDYwoQXo5CF4jOdAg4wrcu2AFh",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:19112",
        "label": "Lometrexol",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C979",
              "label": "Lometrexol"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C979"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(6R)-DDATHF",
          "6R-5,10-Dideazatetrahydrofolate",
          "L-Glutamic Acid, N-(4-(2-((6R)-2-amino-1,4,5,6,7,8-hexahydro-4-oxopyrido(2,3-d)pyrimidin-6-yl)ethyl)benzoyl)-",
          "L-Glutamic Acid, N-(4-(2-(2-amino-1,4,5,6,7,8-hexahydro-4-oxopyrido(2,3-d)pyrimidin-6-yl)ethyl)benzoyl)-, (R)-",
          "Pyrido[2,3-d]pyrimidine, L-glutamic Acid Derivative (9CI)"
        ]
      },
      {
        "id": "civic.tid:86",
        "label": "Mercaptopurine",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:103",
              "label": "mercaptopurine"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C195"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1,7-Dihydro-6H-purine-6-thione",
          "1,7-Dihydro-6H-purine-6-thione Monohydrate",
          "3H-Purine-6-thiol",
          "6 MP",
          "6 Thiohypoxanthine",
          "6 Thiopurine",
          "6-MP",
          "6-Mercaptopurine",
          "6-Mercaptopurine Monohydrate",
          "6-Purinethiol",
          "6-Thiopurine",
          "6-Thioxopurine",
          "6H-Purine-6-thione, 1,7-dihydro- (9CI)",
          "7-Mercapto-1,3,4,6-tetrazaindene",
          "Alti-Mercaptopurine",
          "Azathiopurine",
          "BW 57-323H",
          "Flocofil",
          "Ismipur",
          "Leukerin",
          "Leupurin",
          "Mercaleukim",
          "Mercaleukin",
          "Mercaptina",
          "Mercapto-6-purine",
          "Mercaptopurinum",
          "Mercapurin",
          "Mern",
          "NCI-C04886",
          "Puri-Nethol",
          "Purimethol",
          "Purine, 6-mercapto-",
          "Purine-6-thiol (8CI)",
          "Purine-6-thiol Monohydrate",
          "Purine-6-thiol, Monohydrate",
          "Purinethiol",
          "Purinethol",
          "U-4748",
          "WR-2785"
        ]
      }
    ]
  },
  "civic.tsgid:sRHtqV0Bx8glrh6cOUCk7nrpqP0Eeqrn": {
    "id": "civic.tsgid:sRHtqV0Bx8glrh6cOUCk7nrpqP0Eeqrn",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:422",
        "label": "Methotrexate",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:6851",
              "label": "methotrexate"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": []
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C642"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-Amino-10-methylfolic Acid",
          "4-Amino-4-deoxy-10-methylpteroyl-L-glutamic Acid",
          "Abitrexate",
          "Alpha-Methopterin",
          "Amethopterin",
          "Brimexate",
          "CL 14377",
          "CL-14377",
          "Emtexate",
          "Emthexat",
          "Emthexate",
          "Farmitrexat",
          "Fauldexato",
          "Folex",
          "Folex PFS",
          "Lantarel",
          "Ledertrexate",
          "Lumexon",
          "MTX",
          "Maxtrex",
          "Medsatrexate",
          "Metex",
          "Methoblastin",
          "Methotrexate LPF",
          "Methotrexate Methylaminopterin",
          "Methotrexatum",
          "Metotrexato",
          "Metrotex",
          "Mexate",
          "Mexate-AQ",
          "N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic Acid",
          "Novatrex",
          "Rheumatrex",
          "Texate",
          "Tremetex",
          "Trexeron",
          "Trixilem",
          "WR-19039"
        ]
      },
      {
        "id": "civic.tid:2",
        "label": "Daunorubicin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:3109",
              "label": "daunorubicin"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D007945",
                  "type": "Disease",
                  "label": "Leukemia, Lymphoid",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7539"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015470",
                  "type": "Disease",
                  "label": "Leukemia, Myeloid, Acute",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3171"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62091"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione",
          "5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-",
          "DAUNOMYCIN",
          "DNR",
          "Daunorrubicina",
          "L-lyxo-Hexopyranoside, 3beta-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metldioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-,alpha-",
          "Leukaemomycin C",
          "RUBOMYCIN C",
          "Rubidomycin"
        ]
      },
      {
        "id": "civic.tid:258",
        "label": "Asparaginase",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1156",
              "label": "asparaginase"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "EFO:0000220",
                  "type": "Disease",
                  "label": "acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "MONDO:0000873",
                  "type": "Disease",
                  "label": "lymphoblastic lymphoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9360"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C286"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ASP-1",
          "Asparaginase II",
          "Asparaginase-E.Coli",
          "Colaspase",
          "Elspar",
          "Kidrolase",
          "L-ASP",
          "L-Asnase",
          "L-Asparaginase",
          "L-Asparagine Amidohydrolase",
          "Laspar",
          "Lcf-ASP",
          "Leucogen",
          "Leunase",
          "MK-965",
          "Paronal",
          "Re-82-TAD-15",
          "Serasa",
          "Spectrila"
        ]
      }
    ]
  },
  "civic.tsgid:R8MiNUEpMs_dHqM95yJGpkvXevdk6azb": {
    "id": "civic.tsgid:R8MiNUEpMs_dHqM95yJGpkvXevdk6azb",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:422",
        "label": "Methotrexate",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:6851",
              "label": "methotrexate"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": []
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C642"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-Amino-10-methylfolic Acid",
          "4-Amino-4-deoxy-10-methylpteroyl-L-glutamic Acid",
          "Abitrexate",
          "Alpha-Methopterin",
          "Amethopterin",
          "Brimexate",
          "CL 14377",
          "CL-14377",
          "Emtexate",
          "Emthexat",
          "Emthexate",
          "Farmitrexat",
          "Fauldexato",
          "Folex",
          "Folex PFS",
          "Lantarel",
          "Ledertrexate",
          "Lumexon",
          "MTX",
          "Maxtrex",
          "Medsatrexate",
          "Metex",
          "Methoblastin",
          "Methotrexate LPF",
          "Methotrexate Methylaminopterin",
          "Methotrexatum",
          "Metotrexato",
          "Metrotex",
          "Mexate",
          "Mexate-AQ",
          "N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic Acid",
          "Novatrex",
          "Rheumatrex",
          "Texate",
          "Tremetex",
          "Trexeron",
          "Trixilem",
          "WR-19039"
        ]
      },
      {
        "id": "civic.tid:173",
        "label": "Cytarabine",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:3041",
              "label": "cytarabine"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:575",
                  "type": "Disease",
                  "label": "CNS leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C5440"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:552",
                  "type": "Disease",
                  "label": "Acute myeloid leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3171"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C408"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          ".beta.-Cytosine Arabinoside",
          "1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone",
          "1-.beta.-D-Arabinofuranosylcytosine",
          "1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone",
          "1-Beta-D-arabinofuranosylcytosine",
          "1.beta.-D-Arabinofuranosylcytosine",
          "2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-",
          "2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-",
          "4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone",
          "ARA-cell",
          "Alexan",
          "Ara-C",
          "Arabine",
          "Arabinofuranosylcytosine",
          "Arabinosylcytosine",
          "Aracytidine",
          "Aracytin",
          "Aracytine",
          "Beta-Cytosine Arabinoside",
          "CHX-3311",
          "Cytarabinum",
          "Cytarbel",
          "Cytosar",
          "Cytosar-U",
          "Cytosine Arabinoside",
          "Cytosine-.beta.-arabinoside",
          "Cytosine-beta-arabinoside",
          "Erpalfa",
          "Starasid",
          "Tarabine PFS",
          "U 19920",
          "U-19920",
          "Udicil",
          "WR-28453"
        ]
      },
      {
        "id": "civic.tid:2",
        "label": "Daunorubicin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:3109",
              "label": "daunorubicin"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D007945",
                  "type": "Disease",
                  "label": "Leukemia, Lymphoid",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7539"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015470",
                  "type": "Disease",
                  "label": "Leukemia, Myeloid, Acute",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3171"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62091"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione",
          "5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-",
          "DAUNOMYCIN",
          "DNR",
          "Daunorrubicina",
          "L-lyxo-Hexopyranoside, 3beta-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metldioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-,alpha-",
          "Leukaemomycin C",
          "RUBOMYCIN C",
          "Rubidomycin"
        ]
      },
      {
        "id": "civic.tid:258",
        "label": "Asparaginase",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1156",
              "label": "asparaginase"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "EFO:0000220",
                  "type": "Disease",
                  "label": "acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "MONDO:0000873",
                  "type": "Disease",
                  "label": "lymphoblastic lymphoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9360"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C286"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ASP-1",
          "Asparaginase II",
          "Asparaginase-E.Coli",
          "Colaspase",
          "Elspar",
          "Kidrolase",
          "L-ASP",
          "L-Asnase",
          "L-Asparaginase",
          "L-Asparagine Amidohydrolase",
          "Laspar",
          "Lcf-ASP",
          "Leucogen",
          "Leunase",
          "MK-965",
          "Paronal",
          "Re-82-TAD-15",
          "Serasa",
          "Spectrila"
        ]
      }
    ]
  },
  "civic.tid:1629": {
    "id": "civic.tid:1629",
    "label": "FLT3/ABL/Aurora Kinase Inhibitor KW-2449",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C116858",
          "label": "FLT3/ABL/Aurora Kinase Inhibitor KW-2449"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C116858"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "KW-2449"
    ]
  },
  "civic.ctid:CtWln7v8hgJLNPZj6vZ7dcTMZMT2ZYdx": {
    "id": "civic.ctid:CtWln7v8hgJLNPZj6vZ7dcTMZMT2ZYdx",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:4",
        "label": "Vemurafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1147220",
              "label": "vemurafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:594",
                  "type": "Disease",
                  "label": "Erdheim-Chester disease",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C53972"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C64768"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
          "BRAF (V600E) Kinase Inhibitor RO5185426",
          "BRAF(V600E) Kinase Inhibitor RO5185426",
          "PLX-4032",
          "PLX4032",
          "RG 7204",
          "RG7204",
          "RO 5185426",
          "Zelboraf"
        ]
      },
      {
        "id": "civic.tid:43",
        "label": "Akt Inhibitor MK2206",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C90581",
              "label": "Akt Inhibitor MK2206"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C90581"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1,2,4-Triazolo(3,4-f)(1,6)naphthyridin-3(2H)-one, 8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl-",
          "MK 2206",
          "MK-2206",
          "MK-2206 FREE BASE",
          "MK2206"
        ]
      }
    ]
  },
  "civic.ctid:lBPXvLJKdE1POtYbxr_yzUz79LYLApYN": {
    "id": "civic.ctid:lBPXvLJKdE1POtYbxr_yzUz79LYLApYN",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:4",
        "label": "Vemurafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1147220",
              "label": "vemurafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:629",
                  "type": "Disease",
                  "label": "Melanoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3224"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:594",
                  "type": "Disease",
                  "label": "Erdheim-Chester disease",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C53972"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C64768"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1-propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
          "BRAF (V600E) Kinase Inhibitor RO5185426",
          "BRAF(V600E) Kinase Inhibitor RO5185426",
          "PLX-4032",
          "PLX4032",
          "RG 7204",
          "RG7204",
          "RO 5185426",
          "Zelboraf"
        ]
      },
      {
        "id": "civic.tid:15",
        "label": "Erlotinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:337525",
              "label": "erlotinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:648",
                  "type": "Disease",
                  "label": "Pancreatic cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C43298"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C65530"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent"
      }
    ]
  },
  "civic.tsgid:P-VDb1w-05LwHZRP9cAKSnie8IcKor1c": {
    "id": "civic.tsgid:P-VDb1w-05LwHZRP9cAKSnie8IcKor1c",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:42",
        "label": "Olaparib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1597582",
              "label": "olaparib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:645",
                  "type": "Disease",
                  "label": "Ovarian cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7431"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:648",
                  "type": "Disease",
                  "label": "Pancreatic cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C43298"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:658",
                  "type": "Disease",
                  "label": "Prostate cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7378"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C71721"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AZD 2281",
          "AZD-2281",
          "AZD2281",
          "KU-0059436",
          "Lynparza",
          "PARP Inhibitor AZD2281"
        ]
      },
      {
        "id": "civic.tid:500",
        "label": "Etoposide",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:4179",
              "label": "etoposide"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:671",
                  "type": "Disease",
                  "label": "Testicular cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C5053"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:666",
                  "type": "Disease",
                  "label": "Small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4917"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C491"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4'-Demethylepipodophyllotoxin 9-[4,6-O-ethylidene-beta-D-glucopyranoside]",
          "9-[(4,6-O-Ethylidene-beta-D-glucopyranosyl]oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one",
          "Demethyl Epipodophyllotoxin Ethylidine Glucoside",
          "EPEG",
          "Lastet",
          "Toposar",
          "VP 16",
          "VP 16-213",
          "VP-16",
          "VP-16-213",
          "VP16",
          "Vepesid"
        ]
      }
    ]
  },
  "civic.ctid:Rad3lcAGeG99UmhaaJEnYIfVq2TB5gyS": {
    "id": "civic.ctid:Rad3lcAGeG99UmhaaJEnYIfVq2TB5gyS",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:30",
        "label": "PLX4720",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "drugbank:DB06999",
              "label": "PLX-4720"
            }
          }
        ],
        "type": "TherapeuticAgent"
      },
      {
        "id": "civic.tid:31",
        "label": "Nutlin-3",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "chembl:CHEMBL191334",
              "label": "NUTLIN-3"
            }
          }
        ],
        "type": "TherapeuticAgent"
      }
    ]
  },
  "civic.tid:111": {
    "id": "civic.tid:111",
    "label": "Uprosertib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C84870",
          "label": "Uprosertib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C84870"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "2-Furancarboxamide, N-((1S)-2-Amino-1-((3,4-difluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-",
      "GSK2141795",
      "Oral Akt Inhibitor GSK2141795"
    ]
  },
  "civic.tid:181": {
    "id": "civic.tid:181",
    "label": "Amrubicin",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C80089",
          "label": "Amrubicin"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C80089"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(+)-(7S,9S)-9-Acetyl-9-amino-7-((2-deoxy-beta-D-erythro-pentopyranosyl)oxy)- 6,11-dihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione"
    ]
  },
  "civic.tsgid:WmGNUyuWQ9_7GPOtU24JRzOc2eee7RUA": {
    "id": "civic.tsgid:WmGNUyuWQ9_7GPOtU24JRzOc2eee7RUA",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:187",
        "label": "Osimertinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1721560",
              "label": "osimertinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C116377"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-",
          "AZD-9291",
          "AZD9291",
          "Mereletinib",
          "Tagrisso"
        ]
      },
      {
        "id": "civic.tid:91",
        "label": "Rociletinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C99905",
              "label": "Rociletinib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C99905"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "CO-1686",
          "N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)prop-2-enamide"
        ]
      }
    ]
  },
  "civic.tsgid:v5lZVPkpFbPb9D0fGEzDQe6YBU5CmLdA": {
    "id": "civic.tsgid:v5lZVPkpFbPb9D0fGEzDQe6YBU5CmLdA",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:16",
        "label": "Cetuximab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:318341",
              "label": "cetuximab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D006258",
                  "type": "Disease",
                  "label": "Head and Neck Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4013"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002294",
                  "type": "Disease",
                  "label": "Carcinoma, Squamous Cell",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2929"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1723"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Cetuximab Biosimilar CDP-1",
          "Cetuximab Biosimilar CMAB009",
          "Cetuximab Biosimilar KL 140",
          "Chimeric Anti-EGFR Monoclonal Antibody",
          "Chimeric MoAb C225",
          "Chimeric Monoclonal Antibody C225",
          "Erbitux",
          "IMC-C225"
        ]
      },
      {
        "id": "civic.tid:28",
        "label": "Panitumumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:263034",
              "label": "panitumumab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1857"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABX-EGF",
          "ABX-EGF Monoclonal Antibody",
          "ABX-EGF, Clone E7.6.3",
          "E7.6.3",
          "Human IgG2K Monoclonal Antibody",
          "MoAb ABX-EGF",
          "MoAb E7.6.3",
          "Monoclonal Antibody ABX-EGF",
          "Monoclonal Antibody E7.6.3",
          "Vectibix"
        ]
      },
      {
        "id": "civic.tid:273",
        "label": "Futuximab/Modotuximab Mixture",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C91381",
              "label": "Futuximab/Modotuximab Mixture"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C91381"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Anti-EGFR Monoclonal Antibody Mixture Sym004",
          "Futuximab/Modotuximab",
          "Futuximab/Zatuximab",
          "Sym004"
        ]
      }
    ]
  },
  "civic.ctid:BdRk9XEXwBZytGoulOf00oeavewtOvFC": {
    "id": "civic.ctid:BdRk9XEXwBZytGoulOf00oeavewtOvFC",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:16",
        "label": "Cetuximab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:318341",
              "label": "cetuximab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D006258",
                  "type": "Disease",
                  "label": "Head and Neck Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C4013"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D002294",
                  "type": "Disease",
                  "label": "Carcinoma, Squamous Cell",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2929"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1723"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "Cetuximab Biosimilar CDP-1",
          "Cetuximab Biosimilar CMAB009",
          "Cetuximab Biosimilar KL 140",
          "Chimeric Anti-EGFR Monoclonal Antibody",
          "Chimeric MoAb C225",
          "Chimeric Monoclonal Antibody C225",
          "Erbitux",
          "IMC-C225"
        ]
      },
      {
        "id": "civic.tid:343",
        "label": "Dactolisib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C74072",
              "label": "Dactolisib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C74072"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BEZ235",
          "Benzeneacetonitrile, 4-(2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo(4,5-c)quinolin-1-yl)-alpha,alpha-dimethyl-",
          "NVPBEZ235"
        ]
      }
    ]
  },
  "civic.tid:660": {
    "id": "civic.tid:660",
    "label": "Taselisib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C116876",
          "label": "Taselisib"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C116876"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "GDC-0032",
      "RO5537381"
    ]
  },
  "civic.tid:407": {
    "id": "civic.tid:407",
    "label": "Aromatase Inhibitor",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C1740",
          "label": "Aromatase Inhibitor"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C1740"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tsgid:BxGzt07o7RtpY--kqGrD-2I03DB5WiMa": {
    "id": "civic.tsgid:BxGzt07o7RtpY--kqGrD-2I03DB5WiMa",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:146",
        "label": "Afatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1430438",
              "label": "afatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:642",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2926"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:25316",
                  "type": "Disease",
                  "label": "Non-small cell lung cancer squamous"
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C66940"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(2e)-N-(4-(3-Chloro-4-Fluoroanilino)-7-(((3s)-Oxolan-3-yl)Oxy)Quinoxazolin-6-yl)-4-(Dimethylamino)But-2-Enamide",
          "BIBW 2992",
          "BIBW2992"
        ]
      },
      {
        "id": "civic.tid:247",
        "label": "Pertuzumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1298944",
              "label": "pertuzumab"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D001943",
                  "type": "Disease",
                  "label": "Breast Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2910"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C38692"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "2C4",
          "2C4 Antibody",
          "HS627",
          "Immunoglobulin G1, Anti-(Human V (Receptor)) (Human-Mouse Monoclonal 2C4 Heavy Chain), Disulfide With Human-Mouse Monoclonal 2C4 Kappa-Chain, Dimer",
          "MoAb 2C4",
          "Monoclonal Antibody 2C4",
          "Omnitarg",
          "Perjeta",
          "Pertuzumab Biosimilar HS627",
          "RO4368451",
          "RhuMAb2C4"
        ]
      }
    ]
  },
  "civic.tsgid:7-vqdmeFPTHxXVuEkILH1hUqi8pUpKHI": {
    "id": "civic.tsgid:7-vqdmeFPTHxXVuEkILH1hUqi8pUpKHI",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:19",
        "label": "Trametinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1425098",
              "label": "trametinib dimethyl sulfoxide"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C77908"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "GSK1120212",
          "JTP-74057",
          "MEK Inhibitor GSK1120212",
          "Mekinist",
          "N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide"
        ]
      },
      {
        "id": "civic.tid:63",
        "label": "Selumetinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2289380",
              "label": "selumetinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": []
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C66939"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ARRY-142886",
          "AZD6244",
          "MEK Inhibitor AZD6244"
        ]
      }
    ]
  },
  "civic.ctid:EtvnZkfmUnX9dgYyiWoe5VRjtk66aANb": {
    "id": "civic.ctid:EtvnZkfmUnX9dgYyiWoe5VRjtk66aANb",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:173",
        "label": "Cytarabine",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:3041",
              "label": "cytarabine"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:575",
                  "type": "Disease",
                  "label": "CNS leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C5440"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:582",
                  "type": "Disease",
                  "label": "Chronic myelogenous leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3174"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:552",
                  "type": "Disease",
                  "label": "Acute myeloid leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3171"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:24309",
                  "type": "Disease",
                  "label": "Acute lymphoblastic leukemia",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3167"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C408"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          ".beta.-Cytosine Arabinoside",
          "1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone",
          "1-.beta.-D-Arabinofuranosylcytosine",
          "1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone",
          "1-Beta-D-arabinofuranosylcytosine",
          "1.beta.-D-Arabinofuranosylcytosine",
          "2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-",
          "2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-",
          "4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone",
          "ARA-cell",
          "Alexan",
          "Ara-C",
          "Arabine",
          "Arabinofuranosylcytosine",
          "Arabinosylcytosine",
          "Aracytidine",
          "Aracytin",
          "Aracytine",
          "Beta-Cytosine Arabinoside",
          "CHX-3311",
          "Cytarabinum",
          "Cytarbel",
          "Cytosar",
          "Cytosar-U",
          "Cytosine Arabinoside",
          "Cytosine-.beta.-arabinoside",
          "Cytosine-beta-arabinoside",
          "Erpalfa",
          "Starasid",
          "Tarabine PFS",
          "U 19920",
          "U-19920",
          "Udicil",
          "WR-28453"
        ]
      },
      {
        "id": "civic.tid:157",
        "label": "Sunitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:357977",
              "label": "sunitinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:647",
                  "type": "Disease",
                  "label": "Pancreatic NET",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27720"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C71622"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-"
        ]
      }
    ]
  },
  "civic.ctid:kq_IlYPnxZshE98tdVEBg09-xj3EdRy6": {
    "id": "civic.ctid:kq_IlYPnxZshE98tdVEBg09-xj3EdRy6",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "COMBINATION"
      }
    ],
    "type": "CombinationTherapy",
    "components": [
      {
        "id": "civic.tid:2",
        "label": "Daunorubicin",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:3109",
              "label": "daunorubicin"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D007945",
                  "type": "Disease",
                  "label": "Leukemia, Lymphoid",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C7539"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015470",
                  "type": "Disease",
                  "label": "Leukemia, Myeloid, Acute",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3171"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C62091"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione",
          "5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-",
          "DAUNOMYCIN",
          "DNR",
          "Daunorrubicina",
          "L-lyxo-Hexopyranoside, 3beta-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metldioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-,alpha-",
          "Leukaemomycin C",
          "RUBOMYCIN C",
          "Rubidomycin"
        ]
      },
      {
        "id": "civic.tid:157",
        "label": "Sunitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:357977",
              "label": "sunitinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:647",
                  "type": "Disease",
                  "label": "Pancreatic NET",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27720"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C71622"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-"
        ]
      }
    ]
  },
  "civic.tsgid:bYViGyioquX85upNxP_jx2bCYehx3bhD": {
    "id": "civic.tsgid:bYViGyioquX85upNxP_jx2bCYehx3bhD",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:27",
        "label": "Regorafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1312397",
              "label": "regorafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D015179",
                  "type": "Disease",
                  "label": "Colorectal Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2956"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C78204"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide",
          "BAY 73-4506",
          "REGORAFENIB ANHYDROUS",
          "Stivarga"
        ]
      },
      {
        "id": "civic.tid:157",
        "label": "Sunitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:357977",
              "label": "sunitinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:647",
                  "type": "Disease",
                  "label": "Pancreatic NET",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27720"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:602",
                  "type": "Disease",
                  "label": "Gastrointestinal stromal tumor",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3868"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C71622"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-"
        ]
      }
    ]
  },
  "civic.tid:173": {
    "id": "civic.tid:173",
    "label": "Cytarabine",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:3041",
          "label": "cytarabine"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:575",
              "type": "Disease",
              "label": "CNS leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C5440"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:582",
              "type": "Disease",
              "label": "Chronic myelogenous leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3174"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:552",
              "type": "Disease",
              "label": "Acute myeloid leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3171"
                  },
                  "relation": "relatedMatch"
                }
              ]
            },
            {
              "id": "hemonc:24309",
              "type": "Disease",
              "label": "Acute lymphoblastic leukemia",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C3167"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C408"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      ".beta.-Cytosine Arabinoside",
      "1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone",
      "1-.beta.-D-Arabinofuranosylcytosine",
      "1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone",
      "1-Beta-D-arabinofuranosylcytosine",
      "1.beta.-D-Arabinofuranosylcytosine",
      "2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-",
      "2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-",
      "4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone",
      "ARA-cell",
      "Alexan",
      "Ara-C",
      "Arabine",
      "Arabinofuranosylcytosine",
      "Arabinosylcytosine",
      "Aracytidine",
      "Aracytin",
      "Aracytine",
      "Beta-Cytosine Arabinoside",
      "CHX-3311",
      "Cytarabinum",
      "Cytarbel",
      "Cytosar",
      "Cytosar-U",
      "Cytosine Arabinoside",
      "Cytosine-.beta.-arabinoside",
      "Cytosine-beta-arabinoside",
      "Erpalfa",
      "Starasid",
      "Tarabine PFS",
      "U 19920",
      "U-19920",
      "Udicil",
      "WR-28453"
    ]
  },
  "civic.tsgid:KpOIbC8KoMmAJMv0VhZEeNN81aMernIK": {
    "id": "civic.tsgid:KpOIbC8KoMmAJMv0VhZEeNN81aMernIK",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:343",
        "label": "Dactolisib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C74072",
              "label": "Dactolisib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C74072"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BEZ235",
          "Benzeneacetonitrile, 4-(2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo(4,5-c)quinolin-1-yl)-alpha,alpha-dimethyl-",
          "NVPBEZ235"
        ]
      },
      {
        "id": "civic.tid:84",
        "label": "Trastuzumab",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:2103478",
              "label": "trastuzumab-dkst"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "mesh:D001943",
                  "type": "Disease",
                  "label": "Breast Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C2910"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C1647"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "ABP 980",
          "ALT02",
          "Anti-ERB-2",
          "Anti-HER2/c-erbB2 Monoclonal Antibody",
          "Anti-c-ERB-2",
          "Anti-c-erbB2 Monoclonal Antibody",
          "Anti-erbB-2",
          "Anti-erbB2 Monoclonal Antibody",
          "Anti-p185-HER2",
          "C-erb-2 Monoclonal Antibody",
          "HER2 Monoclonal Antibody",
          "Herceptin",
          "Herceptin Biosimilar PF-05280014",
          "Herceptin Trastuzumab Biosimilar PF-05280014",
          "Herzuma",
          "Immunoglobulin G 1 (Human-Mouse Monoclonal RhuMab HER2gamma1-Chain Antihuman P185(Sup C-erbB2) Receptor), Disulfide With Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer",
          "Kanjinti",
          "MoAb HER2",
          "Monoclonal Antibody C-erb-2",
          "Monoclonal Antibody HER2",
          "Ogivri",
          "Ontruzant",
          "PF-05280014",
          "RO0452317",
          "RhuMAb HER2",
          "SB3",
          "Trastuzumab Biosimilar ABP 980",
          "Trastuzumab Biosimilar ALT02",
          "Trastuzumab Biosimilar EG12014",
          "Trastuzumab Biosimilar HLX02",
          "Trastuzumab Biosimilar PF-05280014",
          "Trastuzumab Biosimilar SB3",
          "Trastuzumab Biosimilar SIBP-01",
          "Trastuzumab-anns",
          "Trastuzumab-dkst",
          "Trastuzumab-dttb",
          "Trastuzumab-pkrb",
          "Trastuzumab-qyyp",
          "Trazimera"
        ]
      },
      {
        "id": "civic.tid:45",
        "label": "Lapatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:480167",
              "label": "lapatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:572",
                  "type": "Disease",
                  "label": "Breast cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9335"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C26653"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "GSK572016",
          "GW 2016",
          "GW2016",
          "GW572016"
        ]
      }
    ]
  },
  "civic.tsgid:M_Sea-m2TfCKdX-BNxASF4JMdFU5Jnj9": {
    "id": "civic.tsgid:M_Sea-m2TfCKdX-BNxASF4JMdFU5Jnj9",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:519",
        "label": "Axitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1242999",
              "label": "axitinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C38718"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "AG-013736",
          "AG013736",
          "Inlyta",
          "N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide"
        ]
      },
      {
        "id": "civic.tid:144",
        "label": "Cabozantinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1363267",
              "label": "cabozantinib s-malate"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:65823",
                  "type": "Disease",
                  "label": "Thyroid cancer differentiated"
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:612",
                  "type": "Disease",
                  "label": "Hepatocellular carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3099"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:68942",
                  "type": "Disease",
                  "label": "Thyroid cancer medullary"
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C52200"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "1,1-Cyclopropanedicarboxamide, N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- Fluorophenyl)-",
          "N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1- Dicarboxamide"
        ]
      },
      {
        "id": "civic.tid:228",
        "label": "Dovitinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C76199",
              "label": "Dovitinib"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C76199"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent"
      },
      {
        "id": "civic.tid:527",
        "label": "Lenvatinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1603296",
              "label": "lenvatinib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:65823",
                  "type": "Disease",
                  "label": "Thyroid cancer differentiated"
                },
                {
                  "id": "hemonc:593",
                  "type": "Disease",
                  "label": "Endometrial cancer",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C27815"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:612",
                  "type": "Disease",
                  "label": "Hepatocellular carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3099"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C95124"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]- 7-methoxy-",
          "E7080",
          "ER-203492-00",
          "Multi-Kinase Inhibitor E7080"
        ]
      }
    ]
  },
  "civic.tid:429": {
    "id": "civic.tid:429",
    "label": "Palbociclib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:1601374",
          "label": "palbociclib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C49176"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-one",
      "Ibrance",
      "PD 0332991",
      "PD 332991",
      "PD 991",
      "PD-0332991",
      "Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)-"
    ]
  },
  "civic.tid:570": {
    "id": "civic.tid:570",
    "label": "Alpelisib",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "rxcui:2169285",
          "label": "alpelisib"
        }
      },
      {
        "type": "Extension",
        "name": "regulatory_approval",
        "value": {
          "approval_rating": "FDA",
          "has_indications": [
            {
              "id": "hemonc:572",
              "type": "Disease",
              "label": "Breast cancer",
              "mappings": [
                {
                  "coding": {
                    "system": "ncit",
                    "code": "C9335"
                  },
                  "relation": "relatedMatch"
                }
              ]
            }
          ]
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C94214"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "BYL719",
      "Phosphoinositide 3-kinase Inhibitor BYL719",
      "Piqray"
    ]
  },
  "civic.tid:19830": {
    "id": "civic.tid:19830",
    "label": "PI-103",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "iuphar.ligand:5701",
          "label": "PI-103"
        }
      }
    ],
    "type": "TherapeuticAgent"
  },
  "civic.tsgid:cI8a1KqlKHGJhEYJvUfvA11fkiIQd--H": {
    "id": "civic.tsgid:cI8a1KqlKHGJhEYJvUfvA11fkiIQd--H",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:6",
        "label": "Sorafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:495881",
              "label": "sorafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:65823",
                  "type": "Disease",
                  "label": "Thyroid cancer differentiated"
                },
                {
                  "id": "hemonc:612",
                  "type": "Disease",
                  "label": "Hepatocellular carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3099"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C61948"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BA4 43 9006",
          "BAY 43-9006",
          "Bay-439006"
        ]
      },
      {
        "id": "civic.tid:110",
        "label": "Mitogen-Activated Protein Kinase Kinase Inhibitor",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "ncit:C69145",
              "label": "Mitogen-Activated Protein Kinase Kinase Inhibitor"
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C69145"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent"
      }
    ]
  },
  "civic.tsgid:DfnGfZruKv7WdSpFN0MrdQY7MH9LeePi": {
    "id": "civic.tsgid:DfnGfZruKv7WdSpFN0MrdQY7MH9LeePi",
    "extensions": [
      {
        "type": "Extension",
        "name": "civic_therapy_interaction_type",
        "value": "SUBSTITUTES"
      }
    ],
    "type": "TherapeuticSubstituteGroup",
    "substitutes": [
      {
        "id": "civic.tid:6",
        "label": "Sorafenib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:495881",
              "label": "sorafenib"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "FDA",
              "has_indications": [
                {
                  "id": "hemonc:65823",
                  "type": "Disease",
                  "label": "Thyroid cancer differentiated"
                },
                {
                  "id": "hemonc:612",
                  "type": "Disease",
                  "label": "Hepatocellular carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3099"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                },
                {
                  "id": "hemonc:660",
                  "type": "Disease",
                  "label": "Renal cell carcinoma",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C9385"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C61948"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "BA4 43 9006",
          "BAY 43-9006",
          "Bay-439006"
        ]
      },
      {
        "id": "civic.tid:19",
        "label": "Trametinib",
        "extensions": [
          {
            "type": "Extension",
            "name": "therapy_normalizer_data",
            "value": {
              "normalized_id": "rxcui:1425098",
              "label": "trametinib dimethyl sulfoxide"
            }
          },
          {
            "type": "Extension",
            "name": "regulatory_approval",
            "value": {
              "approval_rating": "ChEMBL",
              "has_indications": [
                {
                  "id": "mesh:D009369",
                  "type": "Disease",
                  "label": "Neoplasms",
                  "mappings": [
                    {
                      "coding": {
                        "system": "ncit",
                        "code": "C3262"
                      },
                      "relation": "relatedMatch"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "mappings": [
          {
            "coding": {
              "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
              "code": "C77908"
            },
            "relation": "exactMatch"
          }
        ],
        "type": "TherapeuticAgent",
        "aliases": [
          "GSK1120212",
          "JTP-74057",
          "MEK Inhibitor GSK1120212",
          "Mekinist",
          "N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide"
        ]
      }
    ]
  },
  "civic.tid:51": {
    "id": "civic.tid:51",
    "label": "Staurosporine",
    "extensions": [
      {
        "type": "Extension",
        "name": "therapy_normalizer_data",
        "value": {
          "normalized_id": "ncit:C1237",
          "label": "Staurosporine"
        }
      }
    ],
    "mappings": [
      {
        "coding": {
          "system": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=",
          "code": "C1237"
        },
        "relation": "exactMatch"
      }
    ],
    "type": "TherapeuticAgent",
    "aliases": [
      "(9alpha,10beta,11beta,13alpha)-(+)-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H-9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one",
      "8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-",
      "AM-2282",
      "Antibiotic 230",
      "Antibiotic AM 2282",
      "CGP-39360"
    ]
  }
}